Frequencies for first 10,000 rows of pt variable in reac2008q3 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 7 0.07 0.07 ABDOMINAL ABSCESS | 1 0.01 0.08 ABDOMINAL ADHESIONS | 2 0.02 0.10 ABDOMINAL DISCOMFORT | 10 0.10 0.20 ABDOMINAL DISTENSION | 16 0.16 0.36 ABDOMINAL HERNIA REPAIR | 1 0.01 0.37 ABDOMINAL INFECTION | 1 0.01 0.38 ABDOMINAL MASS | 1 0.01 0.39 ABDOMINAL PAIN | 47 0.47 0.86 ABDOMINAL PAIN LOWER | 8 0.08 0.94 ABDOMINAL PAIN UPPER | 29 0.29 1.23 ABDOMINAL TENDERNESS | 2 0.02 1.25 ABNORMAL BEHAVIOUR | 13 0.13 1.38 ABNORMAL DREAMS | 10 0.10 1.48 ABNORMAL FAECES | 2 0.02 1.50 ABNORMAL SENSATION IN EYE | 2 0.02 1.52 ABORTION | 1 0.01 1.53 ABORTION INCOMPLETE | 1 0.01 1.54 ABORTION INDUCED | 1 0.01 1.55 ABORTION MISSED | 1 0.01 1.56 ABORTION SPONTANEOUS | 15 0.15 1.71 ABORTION THREATENED | 1 0.01 1.72 ABSCESS | 8 0.08 1.80 ABSCESS JAW | 3 0.03 1.83 ABSCESS ORAL | 1 0.01 1.84 ACCIDENT AT WORK | 1 0.01 1.85 ACCIDENTAL DEATH | 1 0.01 1.86 ACCIDENTAL DRUG INTAKE BY CHILD | 3 0.03 1.89 ACCIDENTAL EXPOSURE | 3 0.03 1.92 ACCIDENTAL OVERDOSE | 7 0.07 1.99 ACIDOSIS | 2 0.02 2.01 ACNE | 6 0.06 2.07 ACTINOMYCOSIS | 2 0.02 2.09 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 2 0.02 2.11 ACTIVITIES OF DAILY LIVING IMPAIRED | 6 0.06 2.17 ACUTE CORONARY SYNDROME | 5 0.05 2.22 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 2 0.02 2.24 ACUTE GRAFT VERSUS HOST DISEASE | 2 0.02 2.26 ACUTE GRAFT VERSUS HOST DISEASE IN IN.. | 1 0.01 2.27 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN | 2 0.02 2.29 ACUTE HEPATIC FAILURE | 3 0.03 2.32 ACUTE INTERSTITIAL PNEUMONITIS | 1 0.01 2.33 ACUTE LEFT VENTRICULAR FAILURE | 1 0.01 2.34 ACUTE LEUKAEMIA | 1 0.01 2.35 ACUTE LYMPHOCYTIC LEUKAEMIA | 1 0.01 2.36 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT | 1 0.01 2.37 ACUTE MYELOID LEUKAEMIA | 2 0.02 2.39 ACUTE MYOCARDIAL INFARCTION | 6 0.06 2.45 ACUTE PULMONARY OEDEMA | 3 0.03 2.48 ACUTE RESPIRATORY DISTRESS SYNDROME | 3 0.03 2.51 ACUTE RESPIRATORY FAILURE | 3 0.03 2.54 ACUTE SINUSITIS | 1 0.01 2.55 ADRENAL DISORDER | 2 0.02 2.57 ADRENAL HAEMORRHAGE | 1 0.01 2.58 ADRENAL INSUFFICIENCY | 1 0.01 2.59 ADRENAL MASS | 1 0.01 2.60 ADVERSE DRUG REACTION | 9 0.09 2.69 ADVERSE EVENT | 21 0.21 2.90 ADVERSE REACTION | 2 0.02 2.92 AFFECT LABILITY | 3 0.03 2.95 AFFECTIVE DISORDER | 2 0.02 2.97 AGEUSIA | 1 0.01 2.98 AGGRESSION | 16 0.16 3.14 AGITATED DEPRESSION | 1 0.01 3.15 AGITATION | 25 0.25 3.40 AGORAPHOBIA | 1 0.01 3.41 AGRANULOCYTOSIS | 4 0.04 3.45 ALANINE AMINOTRANSFERASE INCREASED | 18 0.18 3.63 ALCOHOL ABUSE | 1 0.01 3.64 ALCOHOL USE | 1 0.01 3.65 ALKALOSIS HYPOCHLORAEMIC | 1 0.01 3.66 ALLERGENIC DESENSITISATION PROCEDURE | 1 0.01 3.67 ALLERGIC GRANULOMATOUS ANGIITIS | 4 0.04 3.71 ALLODYNIA | 1 0.01 3.72 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 1 0.01 3.73 ALOPECIA | 11 0.11 3.84 ALTERED STATE OF CONSCIOUSNESS | 6 0.06 3.90 ALTERED VISUAL DEPTH PERCEPTION | 1 0.01 3.91 AMENORRHOEA | 5 0.05 3.96 AMMONIA INCREASED | 1 0.01 3.97 AMNESIA | 13 0.13 4.10 AMNIOCENTESIS ABNORMAL | 1 0.01 4.11 AMNIOTIC FLUID VOLUME DECREASED | 1 0.01 4.12 AMPHETAMINES POSITIVE | 1 0.01 4.13 AMPUTATION | 1 0.01 4.14 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 4.15 ANAEMIA | 49 0.49 4.64 ANAEMIA MACROCYTIC | 1 0.01 4.65 ANAEMIA NEONATAL | 1 0.01 4.66 ANAEMIA POSTOPERATIVE | 1 0.01 4.67 ANAL ABSCESS | 1 0.01 4.68 ANAL FISTULA | 1 0.01 4.69 ANAPHYLACTIC REACTION | 12 0.12 4.81 ANAPHYLACTIC SHOCK | 11 0.11 4.92 ANAPHYLACTOID REACTION | 2 0.02 4.94 ANAPHYLACTOID SHOCK | 1 0.01 4.95 ANASTOMOTIC COMPLICATION | 1 0.01 4.96 ANEURYSM | 2 0.02 4.98 ANGER | 11 0.11 5.09 ANGINA PECTORIS | 6 0.06 5.15 ANGINA UNSTABLE | 4 0.04 5.19 ANGIOEDEMA | 10 0.10 5.29 ANGIOMYOLIPOMA | 1 0.01 5.30 ANGIOPATHY | 2 0.02 5.32 ANHEDONIA | 15 0.15 5.47 ANIMAL BITE | 1 0.01 5.48 ANKLE FRACTURE | 2 0.02 5.50 ANORECTAL DISORDER | 1 0.01 5.51 ANOREXIA | 39 0.39 5.90 ANOREXIA NERVOSA | 1 0.01 5.91 ANOSMIA | 1 0.01 5.92 ANOXIA | 1 0.01 5.93 ANOXIC ENCEPHALOPATHY | 2 0.02 5.95 ANTI-INSULIN ANTIBODY | 1 0.01 5.96 ANTI-INSULIN ANTIBODY INCREASED | 1 0.01 5.97 ANTI-INSULIN ANTIBODY POSITIVE | 1 0.01 5.98 ANTIBODY TEST POSITIVE | 1 0.01 5.99 ANTICONVULSANT DRUG LEVEL ABOVE THERA.. | 1 0.01 6.00 ANTICONVULSANT DRUG LEVEL DECREASED | 1 0.01 6.01 ANTICONVULSANT DRUG LEVEL INCREASED | 1 0.01 6.02 ANTINUCLEAR ANTIBODY POSITIVE | 1 0.01 6.03 ANTIPHOSPHOLIPID ANTIBODIES | 1 0.01 6.04 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 6.05 ANURIA | 3 0.03 6.08 ANXIETY | 90 0.90 6.98 ANXIETY DISORDER | 2 0.02 7.00 AORTA HYPOPLASIA | 1 0.01 7.01 AORTIC ANEURYSM | 1 0.01 7.02 AORTIC ANEURYSM RUPTURE | 1 0.01 7.03 AORTIC DISORDER | 2 0.02 7.05 AORTIC DISSECTION | 2 0.02 7.07 AORTIC STENOSIS | 1 0.01 7.08 AORTIC VALVE DISEASE | 1 0.01 7.09 AORTIC VALVE INCOMPETENCE | 1 0.01 7.10 AORTIC VALVE STENOSIS | 3 0.03 7.13 APATHY | 3 0.03 7.16 APGAR SCORE LOW | 1 0.01 7.17 APHAGIA | 1 0.01 7.18 APHAKIA | 1 0.01 7.19 APHASIA | 6 0.06 7.25 APHONIA | 1 0.01 7.26 APHTHOUS STOMATITIS | 3 0.03 7.29 APLASIA PURE RED CELL | 1 0.01 7.30 APLASTIC ANAEMIA | 1 0.01 7.31 APNOEA | 5 0.05 7.36 APNOEIC ATTACK | 2 0.02 7.38 APPENDICEAL MUCOCOELE | 1 0.01 7.39 APPENDICECTOMY | 1 0.01 7.40 APPENDICITIS | 3 0.03 7.43 APPENDIX DISORDER | 1 0.01 7.44 APPETITE DISORDER | 1 0.01 7.45 APPLICATION SITE BURN | 4 0.04 7.49 APPLICATION SITE ERYTHEMA | 2 0.02 7.51 APPLICATION SITE PAIN | 1 0.01 7.52 APPLICATION SITE PRURITUS | 1 0.01 7.53 ARRHYTHMIA | 21 0.21 7.74 ARTERIAL OCCLUSIVE DISEASE | 3 0.03 7.77 ARTERIAL STENOSIS | 1 0.01 7.78 ARTERIOSCLEROSIS CORONARY ARTERY | 2 0.02 7.80 ARTERIOSPASM CORONARY | 1 0.01 7.81 ARTHRALGIA | 50 0.50 8.31 ARTHRITIS | 11 0.11 8.42 ARTHRITIS BACTERIAL | 1 0.01 8.43 ARTHROPATHY | 11 0.11 8.54 ARTHROSCOPIC SURGERY | 1 0.01 8.55 ASCITES | 9 0.09 8.64 ASOCIAL BEHAVIOUR | 1 0.01 8.65 ASPARTATE AMINOTRANSFERASE INCREASED | 18 0.18 8.83 ASPERGILLOSIS | 1 0.01 8.84 ASPHYXIA | 1 0.01 8.85 ASPIRATION | 1 0.01 8.86 ASTHENIA | 67 0.67 9.53 ASTHENOPIA | 2 0.02 9.55 ASTHMA | 20 0.20 9.75 ATAXIA | 2 0.02 9.77 ATELECTASIS | 2 0.02 9.79 ATRIAL FIBRILLATION | 26 0.26 10.05 ATRIAL FLUTTER | 1 0.01 10.06 ATRIAL NATRIURETIC PEPTIDE INCREASED | 1 0.01 10.07 ATRIAL SEPTAL DEFECT | 9 0.09 10.16 ATRIAL TACHYCARDIA | 1 0.01 10.17 ATRIAL THROMBOSIS | 1 0.01 10.18 ATRIOVENTRICULAR BLOCK | 3 0.03 10.21 ATRIOVENTRICULAR BLOCK COMPLETE | 3 0.03 10.24 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 3 0.03 10.27 AUTOIMMUNE DISORDER | 2 0.02 10.29 AUTOIMMUNE THROMBOCYTOPENIA | 1 0.01 10.30 AVULSION FRACTURE | 1 0.01 10.31 AZOTAEMIA | 1 0.01 10.32 B-CELL LYMPHOMA | 2 0.02 10.34 BACK DISORDER | 4 0.04 10.38 BACK INJURY | 3 0.03 10.41 BACK PAIN | 39 0.39 10.80 BACTERAEMIA | 1 0.01 10.81 BACTERIAL INFECTION | 3 0.03 10.84 BALANCE DISORDER | 11 0.11 10.95 BARRETT'S OESOPHAGUS | 1 0.01 10.96 BASAL CELL CARCINOMA | 3 0.03 10.99 BASEDOW'S DISEASE | 1 0.01 11.00 BED REST | 1 0.01 11.01 BEDRIDDEN | 5 0.05 11.06 BENIGN INTRACRANIAL HYPERTENSION | 1 0.01 11.07 BETA 2 MICROGLOBULIN URINE INCREASED | 1 0.01 11.08 BICUSPID AORTIC VALVE | 1 0.01 11.09 BILIARY CIRRHOSIS PRIMARY | 2 0.02 11.11 BILIARY CYST | 1 0.01 11.12 BILIRUBIN CONJUGATED INCREASED | 1 0.01 11.13 BIOPSY | 1 0.01 11.14 BIPOLAR DISORDER | 5 0.05 11.19 BIPOLAR I DISORDER | 2 0.02 11.21 BLADDER CANCER | 1 0.01 11.22 BLADDER DISORDER | 2 0.02 11.24 BLADDER PAIN | 2 0.02 11.26 BLAST CELLS ABSENT | 1 0.01 11.27 BLEPHARITIS | 2 0.02 11.29 BLINDNESS | 7 0.07 11.36 BLINDNESS TRANSIENT | 3 0.03 11.39 BLISTER | 5 0.05 11.44 BLOOD ALBUMIN DECREASED | 3 0.03 11.47 BLOOD ALCOHOL INCREASED | 3 0.03 11.50 BLOOD ALKALINE PHOSPHATASE INCREASED | 8 0.08 11.58 BLOOD AMYLASE INCREASED | 1 0.01 11.59 BLOOD BILIRUBIN ABNORMAL | 2 0.02 11.61 BLOOD BILIRUBIN INCREASED | 12 0.12 11.73 BLOOD CALCIUM ABNORMAL | 1 0.01 11.74 BLOOD CALCIUM INCREASED | 2 0.02 11.76 BLOOD CHLORIDE INCREASED | 1 0.01 11.77 BLOOD CHOLESTEROL | 1 0.01 11.78 BLOOD CHOLESTEROL ABNORMAL | 1 0.01 11.79 BLOOD CHOLESTEROL DECREASED | 1 0.01 11.80 BLOOD CHOLESTEROL INCREASED | 12 0.12 11.92 BLOOD CHOLINESTERASE DECREASED | 1 0.01 11.93 BLOOD COUNT ABNORMAL | 1 0.01 11.94 BLOOD CREATINE PHOSPHOKINASE INCREASED | 17 0.17 12.11 BLOOD CREATINE PHOSPHOKINASE MB INCRE.. | 1 0.01 12.12 BLOOD CREATININE INCREASED | 16 0.16 12.28 BLOOD CULTURE POSITIVE | 1 0.01 12.29 BLOOD FIBRINOGEN INCREASED | 1 0.01 12.30 BLOOD GASES ABNORMAL | 1 0.01 12.31 BLOOD GLUCOSE ABNORMAL | 3 0.03 12.34 BLOOD GLUCOSE DECREASED | 10 0.10 12.44 BLOOD GLUCOSE FALSE POSITIVE | 1 0.01 12.45 BLOOD GLUCOSE FLUCTUATION | 3 0.03 12.48 BLOOD GLUCOSE INCREASED | 27 0.27 12.75 BLOOD IMMUNOGLOBULIN A DECREASED | 1 0.01 12.76 BLOOD LACTATE DEHYDROGENASE INCREASED | 8 0.08 12.84 BLOOD MAGNESIUM DECREASED | 1 0.01 12.85 BLOOD OESTROGEN ABNORMAL | 1 0.01 12.86 BLOOD OESTROGEN DECREASED | 1 0.01 12.87 BLOOD PARATHYROID HORMONE ABNORMAL | 1 0.01 12.88 BLOOD PARATHYROID HORMONE INCREASED | 1 0.01 12.89 BLOOD POTASSIUM DECREASED | 8 0.08 12.97 BLOOD POTASSIUM INCREASED | 7 0.07 13.04 BLOOD PRESSURE ABNORMAL | 1 0.01 13.05 BLOOD PRESSURE DECREASED | 10 0.10 13.15 BLOOD PRESSURE DIASTOLIC DECREASED | 1 0.01 13.16 BLOOD PRESSURE FLUCTUATION | 2 0.02 13.18 BLOOD PRESSURE INADEQUATELY CONTROLLED | 2 0.02 13.20 BLOOD PRESSURE INCREASED | 31 0.31 13.51 BLOOD PRESSURE SYSTOLIC DECREASED | 2 0.02 13.53 BLOOD PRESSURE SYSTOLIC INCREASED | 1 0.01 13.54 BLOOD SODIUM DECREASED | 4 0.04 13.58 BLOOD TEST ABNORMAL | 1 0.01 13.59 BLOOD TESTOSTERONE DECREASED | 1 0.01 13.60 BLOOD TESTOSTERONE INCREASED | 2 0.02 13.62 BLOOD TRIGLYCERIDES | 1 0.01 13.63 BLOOD TRIGLYCERIDES ABNORMAL | 1 0.01 13.64 BLOOD TRIGLYCERIDES INCREASED | 7 0.07 13.71 BLOOD UREA INCREASED | 4 0.04 13.75 BLOOD URIC ACID INCREASED | 1 0.01 13.76 BLOOD URINE PRESENT | 11 0.11 13.87 BLOODY DISCHARGE | 1 0.01 13.88 BODY HEIGHT BELOW NORMAL | 1 0.01 13.89 BODY HEIGHT DECREASED | 1 0.01 13.90 BODY TEMPERATURE INCREASED | 4 0.04 13.94 BONE DENSITY DECREASED | 4 0.04 13.98 BONE DISORDER | 6 0.06 14.04 BONE EROSION | 1 0.01 14.05 BONE LESION | 1 0.01 14.06 BONE MARROW FAILURE | 3 0.03 14.09 BONE MARROW TOXICITY | 1 0.01 14.10 BONE NEOPLASM MALIGNANT | 1 0.01 14.11 BONE PAIN | 10 0.10 14.21 BONE SCAN ABNORMAL | 1 0.01 14.22 BONE SWELLING | 1 0.01 14.23 BOWEL MOVEMENT IRREGULARITY | 2 0.02 14.25 BRADYCARDIA | 15 0.15 14.40 BRADYCARDIA NEONATAL | 1 0.01 14.41 BRADYPHRENIA | 2 0.02 14.43 BRAIN ABSCESS | 1 0.01 14.44 BRAIN CONTUSION | 1 0.01 14.45 BRAIN DEATH | 2 0.02 14.47 BRAIN HERNIATION | 3 0.03 14.50 BRAIN LOBECTOMY | 1 0.01 14.51 BRAIN NATRIURETIC PEPTIDE INCREASED | 1 0.01 14.52 BRAIN NEOPLASM | 1 0.01 14.53 BRAIN OEDEMA | 1 0.01 14.54 BRAIN STEM INFARCTION | 1 0.01 14.55 BREAST CANCER | 13 0.13 14.68 BREAST CANCER FEMALE | 2 0.02 14.70 BREAST CANCER MALE | 1 0.01 14.71 BREAST CANCER METASTATIC | 4 0.04 14.75 BREAST CYST | 2 0.02 14.77 BREAST ENLARGEMENT | 1 0.01 14.78 BREAST MASS | 2 0.02 14.80 BREAST PAIN | 2 0.02 14.82 BREAST TENDERNESS | 1 0.01 14.83 BRONCHIAL CARCINOMA | 1 0.01 14.84 BRONCHIAL HYPERREACTIVITY | 1 0.01 14.85 BRONCHIOLITIS | 1 0.01 14.86 BRONCHITIS | 9 0.09 14.95 BRONCHITIS VIRAL | 1 0.01 14.96 BRONCHOALVEOLAR LAVAGE | 1 0.01 14.97 BRONCHOPNEUMONIA | 3 0.03 15.00 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 15.01 BRONCHOSPASM | 7 0.07 15.08 BRUXISM | 1 0.01 15.09 BULIMIA NERVOSA | 1 0.01 15.10 BUNDLE BRANCH BLOCK LEFT | 5 0.05 15.15 BUNDLE BRANCH BLOCK RIGHT | 4 0.04 15.19 BURNING SENSATION | 5 0.05 15.24 BURNS SECOND DEGREE | 2 0.02 15.26 BURNS THIRD DEGREE | 1 0.01 15.27 BURSITIS | 3 0.03 15.30 BURSITIS INFECTIVE STAPHYLOCOCCAL | 1 0.01 15.31 C-REACTIVE PROTEIN DECREASED | 1 0.01 15.32 C-REACTIVE PROTEIN INCREASED | 9 0.09 15.41 CACHEXIA | 1 0.01 15.42 CAESAREAN SECTION | 4 0.04 15.46 CALCULUS URINARY | 1 0.01 15.47 CANDIDIASIS | 6 0.06 15.53 CAPILLARY LEAK SYNDROME | 1 0.01 15.54 CARBOHYDRATE ANTIGEN 125 | 1 0.01 15.55 CARBOHYDRATE ANTIGEN 19-9 INCREASED | 1 0.01 15.56 CARBUNCLE | 1 0.01 15.57 CARCINOEMBRYONIC ANTIGEN INCREASED | 1 0.01 15.58 CARDIAC ARREST | 27 0.27 15.85 CARDIAC DISCOMFORT | 1 0.01 15.86 CARDIAC DISORDER | 21 0.21 16.07 CARDIAC ENZYMES INCREASED | 1 0.01 16.08 CARDIAC FAILURE | 25 0.25 16.33 CARDIAC FAILURE ACUTE | 1 0.01 16.34 CARDIAC FAILURE CONGESTIVE | 21 0.21 16.55 CARDIAC FIBRILLATION | 1 0.01 16.56 CARDIAC FLUTTER | 1 0.01 16.57 CARDIAC MURMUR | 8 0.08 16.65 CARDIAC OPERATION | 2 0.02 16.67 CARDIAC PACEMAKER INSERTION | 2 0.02 16.69 CARDIAC TAMPONADE | 1 0.01 16.70 CARDIAC VALVE DISEASE | 2 0.02 16.72 CARDIO-RESPIRATORY ARREST | 7 0.07 16.79 CARDIOACTIVE DRUG LEVEL INCREASED | 1 0.01 16.80 CARDIOGENIC SHOCK | 2 0.02 16.82 CARDIOMEGALY | 5 0.05 16.87 CARDIOMYOPATHY | 4 0.04 16.91 CARDIOPULMONARY FAILURE | 2 0.02 16.93 CARDIOTOXICITY | 2 0.02 16.95 CARDIOVASCULAR DISORDER | 22 0.22 17.17 CARDIOVASCULAR INSUFFICIENCY | 1 0.01 17.18 CAROTID ARTERY DISEASE | 2 0.02 17.20 CAROTID ARTERY DISSECTION | 1 0.01 17.21 CAROTID ARTERY STENOSIS | 1 0.01 17.22 CAROTID BRUIT | 1 0.01 17.23 CARPAL TUNNEL DECOMPRESSION | 1 0.01 17.24 CARPAL TUNNEL SYNDROME | 2 0.02 17.26 CARTILAGE INJURY | 1 0.01 17.27 CATARACT | 14 0.14 17.41 CATARACT OPERATION | 2 0.02 17.43 CATATONIA | 1 0.01 17.44 CATHETER RELATED COMPLICATION | 2 0.02 17.46 CATHETER RELATED INFECTION | 2 0.02 17.48 CATHETER THROMBOSIS | 1 0.01 17.49 CATHETERISATION CARDIAC | 1 0.01 17.50 CELL DEATH | 1 0.01 17.51 CELLULITIS | 7 0.07 17.58 CENTRAL AUDITORY PROCESSING DISORDER | 1 0.01 17.59 CENTRAL NERVOUS SYSTEM LESION | 1 0.01 17.60 CENTRAL NERVOUS SYSTEM LYMPHOMA | 1 0.01 17.61 CEREBELLAR HAEMANGIOMA | 1 0.01 17.62 CEREBELLAR HAEMATOMA | 1 0.01 17.63 CEREBELLAR INFARCTION | 1 0.01 17.64 CEREBELLAR SYNDROME | 1 0.01 17.65 CEREBRAL ARTERY EMBOLISM | 1 0.01 17.66 CEREBRAL ARTERY THROMBOSIS | 1 0.01 17.67 CEREBRAL ATROPHY | 2 0.02 17.69 CEREBRAL HAEMORRHAGE | 10 0.10 17.79 CEREBRAL INFARCTION | 10 0.10 17.89 CEREBRAL ISCHAEMIA | 4 0.04 17.93 CEREBRAL PALSY | 1 0.01 17.94 CEREBRAL VENTRICLE DILATATION | 1 0.01 17.95 CEREBROVASCULAR ACCIDENT | 52 0.52 18.47 CEREBROVASCULAR DISORDER | 1 0.01 18.48 CEREBROVASCULAR INSUFFICIENCY | 1 0.01 18.49 CERUMEN IMPACTION | 2 0.02 18.51 CERVICAL DYSPLASIA | 3 0.03 18.54 CERVICAL MYELOPATHY | 1 0.01 18.55 CERVICAL VERTEBRAL FRACTURE | 1 0.01 18.56 CHEILITIS | 2 0.02 18.58 CHEMICAL BURN OF SKIN | 2 0.02 18.60 CHEST CRUSHING | 1 0.01 18.61 CHEST DISCOMFORT | 21 0.21 18.82 CHEST PAIN | 29 0.29 19.11 CHEST X-RAY ABNORMAL | 1 0.01 19.12 CHILLS | 18 0.18 19.30 CHLAMYDIAL INFECTION | 1 0.01 19.31 CHLOASMA | 1 0.01 19.32 CHOKING | 4 0.04 19.36 CHOLECYSTITIS | 4 0.04 19.40 CHOLECYSTITIS ACUTE | 1 0.01 19.41 CHOLECYSTITIS INFECTIVE | 1 0.01 19.42 CHOLELITHIASIS | 3 0.03 19.45 CHOLESTASIS | 3 0.03 19.48 CHONDROCALCINOSIS PYROPHOSPHATE | 1 0.01 19.49 CHONDROPATHY | 1 0.01 19.50 CHORIOAMNIONITIS | 1 0.01 19.51 CHROMATURIA | 8 0.08 19.59 CHROMOSOME ANALYSIS ABNORMAL | 1 0.01 19.60 CHRONIC GRAFT VERSUS HOST DISEASE | 2 0.02 19.62 CHRONIC LYMPHOCYTIC LEUKAEMIA | 2 0.02 19.64 CHRONIC MYELOID LEUKAEMIA | 1 0.01 19.65 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 8 0.08 19.73 CHRONIC SINUSITIS | 1 0.01 19.74 CHRONIC TONSILLITIS | 1 0.01 19.75 CIRCULATORY COLLAPSE | 6 0.06 19.81 CIRCUMSTANCE OR INFORMATION CAPABLE O.. | 10 0.10 19.91 CLAVICLE FRACTURE | 1 0.01 19.92 CLEFT LIP | 1 0.01 19.93 CLEFT PALATE | 1 0.01 19.94 CLONUS | 1 0.01 19.95 CLOSTRIDIAL INFECTION | 2 0.02 19.97 CLOSTRIDIUM BACTERAEMIA | 1 0.01 19.98 CLOSTRIDIUM DIFFICILE COLITIS | 8 0.08 20.06 CLUMSINESS | 1 0.01 20.07 CLUSTER HEADACHE | 1 0.01 20.08 CNS VENTRICULITIS | 1 0.01 20.09 COAGULATION TIME PROLONGED | 1 0.01 20.10 COAGULOPATHY | 1 0.01 20.11 COARCTATION OF THE AORTA | 4 0.04 20.15 COCCYDYNIA | 1 0.01 20.16 COELIAC DISEASE | 1 0.01 20.17 COGNITIVE DISORDER | 9 0.09 20.26 COITAL BLEEDING | 1 0.01 20.27 COLD SWEAT | 2 0.02 20.29 COLITIS | 9 0.09 20.38 COLITIS ISCHAEMIC | 2 0.02 20.40 COLITIS MICROSCOPIC | 1 0.01 20.41 COLITIS ULCERATIVE | 8 0.08 20.49 COLLAGEN-VASCULAR DISEASE | 1 0.01 20.50 COLLAPSE OF LUNG | 2 0.02 20.52 COLON ADENOMA | 1 0.01 20.53 COLON CANCER | 2 0.02 20.55 COLON CANCER METASTATIC | 1 0.01 20.56 COLON CANCER RECURRENT | 1 0.01 20.57 COLON NEOPLASM | 1 0.01 20.58 COLONIC OBSTRUCTION | 2 0.02 20.60 COLONIC POLYP | 1 0.01 20.61 COLONOSCOPY | 2 0.02 20.63 COLOSTOMY | 1 0.01 20.64 COLOUR BLINDNESS | 1 0.01 20.65 COLPOSCOPY | 1 0.01 20.66 COMA | 11 0.11 20.77 COMA URAEMIC | 1 0.01 20.78 COMMUNICATION DISORDER | 1 0.01 20.79 COMPARTMENT SYNDROME | 2 0.02 20.81 COMPLETED SUICIDE | 5 0.05 20.86 COMPLICATION OF DEVICE INSERTION | 1 0.01 20.87 COMPLICATION OF DEVICE REMOVAL | 1 0.01 20.88 COMPRESSION FRACTURE | 2 0.02 20.90 COMPULSIVE SEXUAL BEHAVIOUR | 1 0.01 20.91 COMPULSIVE SHOPPING | 3 0.03 20.94 COMPUTERISED TOMOGRAM ABNORMAL | 1 0.01 20.95 CONDITION AGGRAVATED | 15 0.15 21.10 CONFUSIONAL STATE | 58 0.58 21.68 CONGENITAL ANOMALY | 3 0.03 21.71 CONGENITAL AORTIC VALVE INCOMPETENCE | 1 0.01 21.72 CONGENITAL CARDIOVASCULAR ANOMALY | 2 0.02 21.74 CONGENITAL HYPOTHYROIDISM | 1 0.01 21.75 CONGENITAL MITRAL VALVE INCOMPETENCE | 1 0.01 21.76 CONGENITAL MITRAL VALVE STENOSIS | 1 0.01 21.77 CONGENITAL MUSCULOSKELETAL ANOMALY | 1 0.01 21.78 CONGENITAL NYSTAGMUS | 1 0.01 21.79 CONGENITAL SCOLIOSIS | 1 0.01 21.80 CONGESTIVE CARDIOMYOPATHY | 2 0.02 21.82 CONJUNCTIVAL HYPERAEMIA | 1 0.01 21.83 CONJUNCTIVAL OEDEMA | 1 0.01 21.84 CONJUNCTIVITIS | 4 0.04 21.88 CONJUNCTIVITIS VIRAL | 1 0.01 21.89 CONSTIPATION | 27 0.27 22.16 CONTRAST MEDIA REACTION | 1 0.01 22.17 CONTUSION | 12 0.12 22.29 CONVERSION DISORDER | 1 0.01 22.30 CONVULSION | 54 0.54 22.84 COOMBS TEST POSITIVE | 1 0.01 22.85 COORDINATION ABNORMAL | 3 0.03 22.88 COR PULMONALE ACUTE | 1 0.01 22.89 CORNEAL ABSCESS | 1 0.01 22.90 CORNEAL DISORDER | 1 0.01 22.91 CORONARY ARTERY BYPASS | 1 0.01 22.92 CORONARY ARTERY DISEASE | 11 0.11 23.03 CORONARY ARTERY OCCLUSION | 5 0.05 23.08 CORONARY ARTERY RESTENOSIS | 1 0.01 23.09 CORONARY ARTERY STENOSIS | 1 0.01 23.10 COSTOCHONDRITIS | 3 0.03 23.13 COSTOVERTEBRAL ANGLE TENDERNESS | 1 0.01 23.14 COUGH | 36 0.36 23.50 CRANIOSYNOSTOSIS | 1 0.01 23.51 CREATININE RENAL CLEARANCE DECREASED | 1 0.01 23.52 CREPITATIONS | 1 0.01 23.53 CROHN'S DISEASE | 10 0.10 23.63 CRYING | 10 0.10 23.73 CRYSTAL URINE | 1 0.01 23.74 CYANOSIS | 11 0.11 23.85 CYST | 2 0.02 23.87 CYSTITIS | 4 0.04 23.91 CYSTOSTOMY CLOSURE | 1 0.01 23.92 CYTOGENETIC ABNORMALITY | 3 0.03 23.95 CYTOLYTIC HEPATITIS | 5 0.05 24.00 CYTOMEGALOVIRUS ANTIGEN POSITIVE | 1 0.01 24.01 CYTOMEGALOVIRUS ENTEROCOLITIS | 1 0.01 24.02 CYTOMEGALOVIRUS INFECTION | 4 0.04 24.06 DAYDREAMING | 1 0.01 24.07 DEAFNESS | 8 0.08 24.15 DEAFNESS BILATERAL | 1 0.01 24.16 DEAFNESS UNILATERAL | 1 0.01 24.17 DEATH | 63 0.63 24.80 DEATH NEONATAL | 1 0.01 24.81 DECREASED APPETITE | 11 0.11 24.92 DECREASED INTEREST | 1 0.01 24.93 DECUBITUS ULCER | 2 0.02 24.95 DEEP VEIN THROMBOSIS | 15 0.15 25.10 DEFICIENCY ANAEMIA | 1 0.01 25.11 DEHYDRATION | 34 0.34 25.45 DELAYED RECOVERY FROM ANAESTHESIA | 1 0.01 25.46 DELIRIUM | 12 0.12 25.58 DELUSION | 3 0.03 25.61 DEMENTIA | 9 0.09 25.70 DEMENTIA ALZHEIMER'S TYPE | 1 0.01 25.71 DEMYELINATING POLYNEUROPATHY | 2 0.02 25.73 DEMYELINATION | 5 0.05 25.78 DENGUE FEVER | 1 0.01 25.79 DENNIE-MORGAN FOLD | 1 0.01 25.80 DENTAL CARIES | 8 0.08 25.88 DENTAL NECROSIS | 1 0.01 25.89 DENTAL OPERATION | 1 0.01 25.90 DEPENDENCE | 2 0.02 25.92 DEPERSONALISATION | 3 0.03 25.95 DEPRESSED LEVEL OF CONSCIOUSNESS | 8 0.08 26.03 DEPRESSED MOOD | 8 0.08 26.11 DEPRESSION | 89 0.89 27.00 DERMATITIS | 1 0.01 27.01 DERMATITIS ALLERGIC | 2 0.02 27.03 DERMATITIS BULLOUS | 3 0.03 27.06 DERMATITIS EXFOLIATIVE | 3 0.03 27.09 DERMATITIS INFECTED | 1 0.01 27.10 DERMATOMYOSITIS | 1 0.01 27.11 DERMATOSIS | 1 0.01 27.12 DETOXIFICATION | 1 0.01 27.13 DEVELOPMENTAL DELAY | 3 0.03 27.16 DEVICE INTERACTION | 1 0.01 27.17 DEVICE MALFUNCTION | 4 0.04 27.21 DIABETES INSIPIDUS | 1 0.01 27.22 DIABETES MELLITUS | 15 0.15 27.37 DIABETES MELLITUS INADEQUATE CONTROL | 2 0.02 27.39 DIABETIC COMA | 1 0.01 27.40 DIABETIC HYPEROSMOLAR COMA | 1 0.01 27.41 DIABETIC KETOACIDOSIS | 4 0.04 27.45 DIABETIC NEPHROPATHY | 1 0.01 27.46 DIABETIC RETINOPATHY | 1 0.01 27.47 DIALYSIS | 4 0.04 27.51 DIAPHRAGMATIC HERNIA | 1 0.01 27.52 DIARRHOEA | 70 0.70 28.22 DIARRHOEA HAEMORRHAGIC | 1 0.01 28.23 DIASTOLIC DYSFUNCTION | 1 0.01 28.24 DIFFUSE ALVEOLAR DAMAGE | 1 0.01 28.25 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT | 1 0.01 28.26 DILATATION ATRIAL | 1 0.01 28.27 DILATATION VENTRICULAR | 2 0.02 28.29 DIPLEGIA | 1 0.01 28.30 DIPLOPIA | 10 0.10 28.40 DISABILITY | 5 0.05 28.45 DISABLED RELATIVE | 1 0.01 28.46 DISCOMFORT | 3 0.03 28.49 DISEASE PROGRESSION | 11 0.11 28.60 DISEASE RECURRENCE | 2 0.02 28.62 DISORIENTATION | 12 0.12 28.74 DISSEMINATED INTRAVASCULAR COAGULATION | 3 0.03 28.77 DISSEMINATED TUBERCULOSIS | 2 0.02 28.79 DISSOCIATION | 1 0.01 28.80 DISSOCIATIVE DISORDER | 1 0.01 28.81 DISTURBANCE IN ATTENTION | 12 0.12 28.93 DIVERTICULITIS | 6 0.06 28.99 DIVERTICULUM | 7 0.07 29.06 DIVERTICULUM INTESTINAL | 1 0.01 29.07 DIVORCED | 1 0.01 29.08 DIZZINESS | 98 0.98 30.06 DOCUMENTED HYPERSENSITIVITY TO ADMINI.. | 1 0.01 30.07 DOUBLE OUTLET RIGHT VENTRICLE | 1 0.01 30.08 DROOLING | 1 0.01 30.09 DRUG ABUSE | 7 0.07 30.16 DRUG ADMINISTRATION ERROR | 5 0.05 30.21 DRUG DEPENDENCE | 5 0.05 30.26 DRUG DISPENSING ERROR | 25 0.25 30.51 DRUG DOSE OMISSION | 7 0.07 30.58 DRUG EFFECT DECREASED | 7 0.07 30.65 DRUG EFFECT INCREASED | 2 0.02 30.67 DRUG ERUPTION | 4 0.04 30.71 DRUG EXPOSURE BEFORE PREGNANCY | 1 0.01 30.72 DRUG EXPOSURE DURING PREGNANCY | 39 0.39 31.11 DRUG EXPOSURE VIA BREAST MILK | 2 0.02 31.13 DRUG HYPERSENSITIVITY | 15 0.15 31.28 DRUG INEFFECTIVE | 88 0.88 32.16 DRUG INTERACTION | 46 0.46 32.62 DRUG INTOLERANCE | 5 0.05 32.67 DRUG LEVEL INCREASED | 3 0.03 32.70 DRUG PRESCRIBING ERROR | 3 0.03 32.73 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 4 0.04 32.77 DRUG RESISTANCE | 1 0.01 32.78 DRUG SCREEN FALSE POSITIVE | 1 0.01 32.79 DRUG SCREEN POSITIVE | 1 0.01 32.80 DRUG TOLERANCE | 1 0.01 32.81 DRUG TOXICITY | 11 0.11 32.92 DRUG WITHDRAWAL HEADACHE | 1 0.01 32.93 DRUG WITHDRAWAL SYNDROME | 7 0.07 33.00 DRY EYE | 6 0.06 33.06 DRY MOUTH | 12 0.12 33.18 DRY SKIN | 8 0.08 33.26 DRY THROAT | 2 0.02 33.28 DUODENAL STENOSIS | 1 0.01 33.29 DUODENAL ULCER | 1 0.01 33.30 DUPUYTREN'S CONTRACTURE | 2 0.02 33.32 DYSAESTHESIA | 1 0.01 33.33 DYSARTHRIA | 11 0.11 33.44 DYSGEUSIA | 11 0.11 33.55 DYSGRAPHIA | 1 0.01 33.56 DYSKINESIA | 5 0.05 33.61 DYSMENORRHOEA | 1 0.01 33.62 DYSMORPHISM | 2 0.02 33.64 DYSPAREUNIA | 2 0.02 33.66 DYSPEPSIA | 10 0.10 33.76 DYSPHAGIA | 15 0.15 33.91 DYSPHASIA | 1 0.01 33.92 DYSPHONIA | 8 0.08 34.00 DYSPLASTIC NAEVUS SYNDROME | 1 0.01 34.01 DYSPNOEA | 106 1.06 35.07 DYSPNOEA EXERTIONAL | 7 0.07 35.14 DYSSTASIA | 5 0.05 35.19 DYSTHYMIC DISORDER | 1 0.01 35.20 DYSTONIA | 1 0.01 35.21 DYSURIA | 7 0.07 35.28 EAR DISCOMFORT | 1 0.01 35.29 EAR DISORDER | 2 0.02 35.31 EAR INFECTION | 2 0.02 35.33 EAR PAIN | 2 0.02 35.35 EARLY SATIETY | 1 0.01 35.36 EATING DISORDER | 6 0.06 35.42 EBSTEIN'S ANOMALY | 1 0.01 35.43 ECCHYMOSIS | 5 0.05 35.48 ECHOGRAPHY ABNORMAL | 1 0.01 35.49 ECTOPIC PREGNANCY | 1 0.01 35.50 ECTOPIC PREGNANCY WITH INTRAUTERINE D.. | 2 0.02 35.52 ECZEMA | 6 0.06 35.58 ECZEMA HERPETICUM | 1 0.01 35.59 EDENTULOUS | 1 0.01 35.60 EDUCATIONAL PROBLEM | 1 0.01 35.61 EJECTION FRACTION DECREASED | 2 0.02 35.63 ELECTRIC SHOCK | 1 0.01 35.64 ELECTROCARDIOGRAM ABNORMAL | 2 0.02 35.66 ELECTROCARDIOGRAM CHANGE | 1 0.01 35.67 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED | 2 0.02 35.69 ELECTROCARDIOGRAM QT PROLONGED | 10 0.10 35.79 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL | 1 0.01 35.80 ELECTROENCEPHALOGRAM ABNORMAL | 2 0.02 35.82 ELECTROLYTE IMBALANCE | 1 0.01 35.83 ELECTROMECHANICAL DISSOCIATION | 1 0.01 35.84 ELECTROMYOGRAM ABNORMAL | 1 0.01 35.85 EMBOLIC STROKE | 1 0.01 35.86 EMBOLISM | 2 0.02 35.88 EMOTIONAL DISORDER | 2 0.02 35.90 EMOTIONAL DISTRESS | 16 0.16 36.06 EMPHYSEMA | 6 0.06 36.12 EMPYEMA | 2 0.02 36.14 ENCEPHALITIS HERPES | 1 0.01 36.15 ENCEPHALITIS VIRAL | 2 0.02 36.17 ENCEPHALOPATHY | 5 0.05 36.22 ENDOCARDITIS | 1 0.01 36.23 ENDOMETRIAL DISORDER | 1 0.01 36.24 ENDOMETRIAL HYPERTROPHY | 1 0.01 36.25 ENDOMETRIOSIS | 1 0.01 36.26 ENDOPHTHALMITIS | 1 0.01 36.27 ENDOTRACHEAL INTUBATION COMPLICATION | 1 0.01 36.28 ENGRAFTMENT SYNDROME | 1 0.01 36.29 ENTERITIS | 1 0.01 36.30 ENTERITIS INFECTIOUS | 1 0.01 36.31 ENTEROCOCCAL INFECTION | 4 0.04 36.35 ENTEROCOLITIS | 1 0.01 36.36 ENTEROCOLITIS HAEMORRHAGIC | 1 0.01 36.37 ENURESIS | 2 0.02 36.39 EOSINOPHIL COUNT INCREASED | 1 0.01 36.40 EOSINOPHILIA | 4 0.04 36.44 EPIDERMAL NECROSIS | 1 0.01 36.45 EPIDURAL ANAESTHESIA | 1 0.01 36.46 EPIGLOTTITIS | 1 0.01 36.47 EPILEPSY | 9 0.09 36.56 EPISTAXIS | 7 0.07 36.63 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE | 1 0.01 36.64 EPSTEIN-BARR VIRUS INFECTION | 1 0.01 36.65 ERECTILE DYSFUNCTION | 4 0.04 36.69 ERECTION INCREASED | 1 0.01 36.70 EROSIVE DUODENITIS | 2 0.02 36.72 ERUCTATION | 1 0.01 36.73 ERYSIPELAS | 2 0.02 36.75 ERYSIPELOID | 1 0.01 36.76 ERYTHEMA | 23 0.23 36.99 ERYTHEMA MULTIFORME | 2 0.02 37.01 ERYTHROMELALGIA | 1 0.01 37.02 ESCHERICHIA INFECTION | 1 0.01 37.03 ESCHERICHIA SEPSIS | 2 0.02 37.05 ESCHERICHIA URINARY TRACT INFECTION | 1 0.01 37.06 ESSENTIAL HYPERTENSION | 1 0.01 37.07 ESSENTIAL TREMOR | 2 0.02 37.09 EXCORIATION | 2 0.02 37.11 EXFOLIATIVE RASH | 3 0.03 37.14 EXOPHTHALMOS | 1 0.01 37.15 EXOSTOSIS | 1 0.01 37.16 EXPIRED DRUG ADMINISTERED | 2 0.02 37.18 EXTRANODAL MARGINAL ZONE B-CELL LYMPH.. | 1 0.01 37.19 EXTRAPYRAMIDAL DISORDER | 3 0.03 37.22 EYE DISORDER | 10 0.10 37.32 EYE HAEMORRHAGE | 6 0.06 37.38 EYE INFECTION FUNGAL | 1 0.01 37.39 EYE IRRITATION | 4 0.04 37.43 EYE MOVEMENT DISORDER | 1 0.01 37.44 EYE OPERATION | 1 0.01 37.45 EYE PAIN | 8 0.08 37.53 EYE PRURITUS | 1 0.01 37.54 EYE SWELLING | 1 0.01 37.55 EYELID DISORDER | 2 0.02 37.57 EYELID FUNCTION DISORDER | 1 0.01 37.58 EYELID OEDEMA | 3 0.03 37.61 EYELID PTOSIS | 2 0.02 37.63 FACE INJURY | 2 0.02 37.65 FACE OEDEMA | 4 0.04 37.69 FACIAL NEURALGIA | 1 0.01 37.70 FACIAL PALSY | 4 0.04 37.74 FACIAL SPASM | 1 0.01 37.75 FACTOR V DEFICIENCY | 1 0.01 37.76 FACTOR VII DEFICIENCY | 1 0.01 37.77 FAECAL INCONTINENCE | 2 0.02 37.79 FAECAL VOLUME DECREASED | 1 0.01 37.80 FAECALOMA | 1 0.01 37.81 FAECES DISCOLOURED | 1 0.01 37.82 FAECES HARD | 2 0.02 37.84 FAILURE TO THRIVE | 3 0.03 37.87 FALL | 62 0.62 38.49 FALLOT'S TETRALOGY | 3 0.03 38.52 FAMILY STRESS | 1 0.01 38.53 FAT EMBOLISM | 1 0.01 38.54 FATIGUE | 80 0.80 39.34 FEAR | 20 0.20 39.54 FEBRILE BONE MARROW APLASIA | 1 0.01 39.55 FEBRILE NEUTROPENIA | 10 0.10 39.65 FEEDING DISORDER NEONATAL | 1 0.01 39.66 FEELING ABNORMAL | 27 0.27 39.93 FEELING COLD | 2 0.02 39.95 FEELING DRUNK | 5 0.05 40.00 FEELING HOT | 7 0.07 40.07 FEELING JITTERY | 2 0.02 40.09 FEELING OF BODY TEMPERATURE CHANGE | 1 0.01 40.10 FEELING OF DESPAIR | 1 0.01 40.11 FEELINGS OF WORTHLESSNESS | 1 0.01 40.12 FEMALE GENITAL TRACT FISTULA | 1 0.01 40.13 FEMORAL ARTERY OCCLUSION | 1 0.01 40.14 FEMORAL NECK FRACTURE | 3 0.03 40.17 FEMUR FRACTURE | 4 0.04 40.21 FIBRIN D DIMER INCREASED | 1 0.01 40.22 FIBRIN DEGRADATION PRODUCTS INCREASED | 1 0.01 40.23 FIBROADENOMA OF BREAST | 1 0.01 40.24 FIBROMA | 1 0.01 40.25 FIBROMYALGIA | 4 0.04 40.29 FIBROSIS | 6 0.06 40.35 FISTULA | 4 0.04 40.39 FISTULA DISCHARGE | 1 0.01 40.40 FISTULA REPAIR | 1 0.01 40.41 FLANK PAIN | 3 0.03 40.44 FLATULENCE | 8 0.08 40.52 FLIGHT OF IDEAS | 1 0.01 40.53 FLUID INTAKE REDUCED | 1 0.01 40.54 FLUID OVERLOAD | 3 0.03 40.57 FLUID RETENTION | 5 0.05 40.62 FLUSHING | 9 0.09 40.71 FOAMING AT MOUTH | 2 0.02 40.73 FOETAL DISTRESS SYNDROME | 2 0.02 40.75 FOETAL GROWTH RETARDATION | 1 0.01 40.76 FOETAL HEART RATE DECELERATION | 1 0.01 40.77 FOETAL HEART RATE DECREASED | 1 0.01 40.78 FOETAL HYPOKINESIA | 2 0.02 40.80 FOLLICULITIS | 1 0.01 40.81 FOOD CRAVING | 1 0.01 40.82 FOOD INTERACTION | 1 0.01 40.83 FOOT FRACTURE | 3 0.03 40.86 FOOT OPERATION | 1 0.01 40.87 FORMICATION | 4 0.04 40.91 FRACTURE | 2 0.02 40.93 FREEZING PHENOMENON | 1 0.01 40.94 FREQUENT BOWEL MOVEMENTS | 1 0.01 40.95 FRUSTRATION | 2 0.02 40.97 FULL BLOOD COUNT ABNORMAL | 1 0.01 40.98 FULL BLOOD COUNT DECREASED | 5 0.05 41.03 FUNGAL INFECTION | 13 0.13 41.16 FUNGAL SKIN INFECTION | 1 0.01 41.17 FURUNCLE | 1 0.01 41.18 GAIT DEVIATION | 1 0.01 41.19 GAIT DISTURBANCE | 14 0.14 41.33 GALLBLADDER DISORDER | 6 0.06 41.39 GALLBLADDER OPERATION | 2 0.02 41.41 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 4 0.04 41.45 GANGRENE | 2 0.02 41.47 GASTRECTOMY | 1 0.01 41.48 GASTRIC CANCER | 4 0.04 41.52 GASTRIC DISORDER | 8 0.08 41.60 GASTRIC HAEMORRHAGE | 5 0.05 41.65 GASTRIC PERFORATION | 1 0.01 41.66 GASTRIC POLYPS | 1 0.01 41.67 GASTRIC ULCER | 11 0.11 41.78 GASTRIC ULCER HAEMORRHAGE | 1 0.01 41.79 GASTRIC ULCER PERFORATION | 1 0.01 41.80 GASTRITIS | 7 0.07 41.87 GASTRITIS EROSIVE | 4 0.04 41.91 GASTROENTERITIS | 6 0.06 41.97 GASTROINTESTINAL DISORDER | 11 0.11 42.08 GASTROINTESTINAL FUNGAL INFECTION | 1 0.01 42.09 GASTROINTESTINAL HAEMORRHAGE | 14 0.14 42.23 GASTROINTESTINAL INFECTION | 3 0.03 42.26 GASTROINTESTINAL PAIN | 2 0.02 42.28 GASTROINTESTINAL ULCER HAEMORRHAGE | 1 0.01 42.29 GASTROOESOPHAGEAL REFLUX DISEASE | 12 0.12 42.41 GASTROPTOSIS | 1 0.01 42.42 GENERAL PHYSICAL HEALTH DETERIORATION | 19 0.19 42.61 GENERALISED ERYTHEMA | 1 0.01 42.62 GENERALISED OEDEMA | 6 0.06 42.68 GENITAL HAEMORRHAGE | 5 0.05 42.73 GENITAL PAIN | 2 0.02 42.75 GENITAL RASH | 1 0.01 42.76 GERM CELL CANCER | 1 0.01 42.77 GINGIVAL ABSCESS | 1 0.01 42.78 GINGIVAL BLEEDING | 7 0.07 42.85 GINGIVAL DISCOLOURATION | 1 0.01 42.86 GINGIVAL DISORDER | 2 0.02 42.88 GINGIVAL OEDEMA | 1 0.01 42.89 GINGIVAL PAIN | 1 0.01 42.90 GINGIVAL RECESSION | 1 0.01 42.91 GINGIVAL SWELLING | 1 0.01 42.92 GINGIVITIS | 2 0.02 42.94 GLAUCOMA | 4 0.04 42.98 GLOBAL AMNESIA | 1 0.01 42.99 GLOMERULAR FILTRATION RATE DECREASED | 1 0.01 43.00 GLOMERULONEPHRITIS | 3 0.03 43.03 GLOSSODYNIA | 3 0.03 43.06 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 43.07 GLUCOSE URINE PRESENT | 1 0.01 43.08 GLYCOSYLATED HAEMOGLOBIN INCREASED | 2 0.02 43.10 GOITRE | 2 0.02 43.12 GOUT | 3 0.03 43.15 GRAFT VERSUS HOST DISEASE | 1 0.01 43.16 GRAND MAL CONVULSION | 9 0.09 43.25 GRANULAR CELL TUMOUR | 1 0.01 43.26 GRANULOCYTE COUNT DECREASED | 1 0.01 43.27 GRANULOCYTOPENIA | 2 0.02 43.29 GRANULOMA | 1 0.01 43.30 GRANULOMA SKIN | 1 0.01 43.31 GRANULOMATOUS LIVER DISEASE | 1 0.01 43.32 GRIP STRENGTH DECREASED | 1 0.01 43.33 GROIN PAIN | 1 0.01 43.34 GROWTH RETARDATION | 2 0.02 43.36 HAEMANGIOMA OF LIVER | 1 0.01 43.37 HAEMANGIOMA OF SKIN | 1 0.01 43.38 HAEMATEMESIS | 6 0.06 43.44 HAEMATOCHEZIA | 7 0.07 43.51 HAEMATOCRIT DECREASED | 8 0.08 43.59 HAEMATOCRIT INCREASED | 1 0.01 43.60 HAEMATOMA | 9 0.09 43.69 HAEMATURIA | 7 0.07 43.76 HAEMODYNAMIC INSTABILITY | 1 0.01 43.77 HAEMOGLOBIN | 1 0.01 43.78 HAEMOGLOBIN ABNORMAL | 1 0.01 43.79 HAEMOGLOBIN DECREASED | 14 0.14 43.93 HAEMOGLOBIN INCREASED | 1 0.01 43.94 HAEMOGLOBINURIA | 1 0.01 43.95 HAEMOLYSIS | 2 0.02 43.97 HAEMOLYTIC ANAEMIA | 6 0.06 44.03 HAEMOLYTIC URAEMIC SYNDROME | 1 0.01 44.04 HAEMOPTYSIS | 10 0.10 44.14 HAEMORRHAGE | 16 0.16 44.30 HAEMORRHAGE INTRACRANIAL | 5 0.05 44.35 HAEMORRHAGE SUBCUTANEOUS | 3 0.03 44.38 HAEMORRHAGE URINARY TRACT | 2 0.02 44.40 HAEMORRHAGIC ANAEMIA | 2 0.02 44.42 HAEMORRHAGIC CEREBRAL INFARCTION | 2 0.02 44.44 HAEMORRHAGIC DIATHESIS | 1 0.01 44.45 HAEMORRHAGIC OVARIAN CYST | 1 0.01 44.46 HAEMORRHAGIC STROKE | 1 0.01 44.47 HAEMORRHOIDAL HAEMORRHAGE | 1 0.01 44.48 HAEMORRHOIDS | 1 0.01 44.49 HAIR DISORDER | 1 0.01 44.50 HALLUCINATION | 19 0.19 44.69 HALLUCINATION, AUDITORY | 7 0.07 44.76 HALLUCINATION, OLFACTORY | 1 0.01 44.77 HALLUCINATION, VISUAL | 7 0.07 44.84 HALLUCINATIONS, MIXED | 2 0.02 44.86 HAND DEFORMITY | 1 0.01 44.87 HAPTOGLOBIN DECREASED | 1 0.01 44.88 HEAD BANGING | 1 0.01 44.89 HEAD DISCOMFORT | 1 0.01 44.90 HEAD INJURY | 5 0.05 44.95 HEADACHE | 83 0.83 45.78 HEARING IMPAIRED | 1 0.01 45.79 HEART DISEASE CONGENITAL | 2 0.02 45.81 HEART INJURY | 7 0.07 45.88 HEART RATE DECREASED | 3 0.03 45.91 HEART RATE INCREASED | 12 0.12 46.03 HEART RATE IRREGULAR | 12 0.12 46.15 HEART SOUNDS ABNORMAL | 1 0.01 46.16 HEART TRANSPLANT | 1 0.01 46.17 HELICOBACTER INFECTION | 1 0.01 46.18 HELICOBACTER PYLORI IDENTIFICATION TE.. | 1 0.01 46.19 HEMICEPHALALGIA | 1 0.01 46.20 HEMIPARESIS | 3 0.03 46.23 HEMIPLEGIA | 1 0.01 46.24 HENOCH-SCHONLEIN PURPURA | 2 0.02 46.26 HEPARIN-INDUCED THROMBOCYTOPENIA | 2 0.02 46.28 HEPATIC CIRRHOSIS | 5 0.05 46.33 HEPATIC CYST | 3 0.03 46.36 HEPATIC ENCEPHALOPATHY | 1 0.01 46.37 HEPATIC ENZYME INCREASED | 15 0.15 46.52 HEPATIC FAILURE | 11 0.11 46.63 HEPATIC FUNCTION ABNORMAL | 12 0.12 46.75 HEPATIC HAEMORRHAGE | 1 0.01 46.76 HEPATIC LESION | 3 0.03 46.79 HEPATIC NECROSIS | 2 0.02 46.81 HEPATIC NEOPLASM MALIGNANT | 1 0.01 46.82 HEPATIC NEOPLASM MALIGNANT RECURRENT | 1 0.01 46.83 HEPATIC STEATOSIS | 9 0.09 46.92 HEPATITIS | 12 0.12 47.04 HEPATITIS ACUTE | 2 0.02 47.06 HEPATITIS B | 3 0.03 47.09 HEPATITIS B DNA INCREASED | 1 0.01 47.10 HEPATITIS C | 1 0.01 47.11 HEPATITIS CHOLESTATIC | 2 0.02 47.13 HEPATITIS FULMINANT | 1 0.01 47.14 HEPATITIS TOXIC | 1 0.01 47.15 HEPATOCELLULAR INJURY | 1 0.01 47.16 HEPATOJUGULAR REFLUX | 1 0.01 47.17 HEPATOMEGALY | 7 0.07 47.24 HEPATORENAL SYNDROME | 1 0.01 47.25 HEPATOSPLENIC T-CELL LYMPHOMA | 2 0.02 47.27 HEPATOTOXICITY | 8 0.08 47.35 HERNIA OBSTRUCTIVE | 1 0.01 47.36 HERNIA REPAIR | 1 0.01 47.37 HERPES SIMPLEX | 3 0.03 47.40 HERPES VIRUS INFECTION | 2 0.02 47.42 HERPES ZOSTER | 4 0.04 47.46 HERPES ZOSTER OTICUS | 1 0.01 47.47 HIATUS HERNIA | 8 0.08 47.55 HICCUPS | 3 0.03 47.58 HIP ARTHROPLASTY | 4 0.04 47.62 HIP FRACTURE | 9 0.09 47.71 HIP SURGERY | 2 0.02 47.73 HIRSUTISM | 1 0.01 47.74 HISTIOCYTOSIS HAEMATOPHAGIC | 2 0.02 47.76 HODGKIN'S DISEASE | 2 0.02 47.78 HODGKIN'S DISEASE STAGE II | 1 0.01 47.79 HOMICIDAL IDEATION | 4 0.04 47.83 HOMICIDE | 1 0.01 47.84 HOSPITALISATION | 11 0.11 47.95 HOSTILITY | 2 0.02 47.97 HOT FLUSH | 10 0.10 48.07 HUMAN POLYOMAVIRUS INFECTION | 2 0.02 48.09 HUMERUS FRACTURE | 1 0.01 48.10 HUNGER | 1 0.01 48.11 HYDROCEPHALUS | 1 0.01 48.12 HYDROMETRA | 1 0.01 48.13 HYDRONEPHROSIS | 1 0.01 48.14 HYPERACUSIS | 2 0.02 48.16 HYPERAMMONAEMIA | 1 0.01 48.17 HYPERBARIC OXYGEN THERAPY | 5 0.05 48.22 HYPERBILIRUBINAEMIA | 1 0.01 48.23 HYPERBILIRUBINAEMIA NEONATAL | 1 0.01 48.24 HYPERCALCAEMIA | 4 0.04 48.28 HYPERCAPNIA | 3 0.03 48.31 HYPERCHOLESTEROLAEMIA | 1 0.01 48.32 HYPERCOAGULATION | 2 0.02 48.34 HYPERGLYCAEMIA | 13 0.13 48.47 HYPERHIDROSIS | 28 0.28 48.75 HYPERKALAEMIA | 9 0.09 48.84 HYPERKERATOSIS PALMARIS AND PLANTARIS | 1 0.01 48.85 HYPERLIPIDAEMIA | 7 0.07 48.92 HYPERMETROPIA | 1 0.01 48.93 HYPERNATRAEMIA | 1 0.01 48.94 HYPERPARATHYROIDISM PRIMARY | 1 0.01 48.95 HYPERPHAGIA | 1 0.01 48.96 HYPERSENSITIVITY | 16 0.16 49.12 HYPERSEXUALITY | 8 0.08 49.20 HYPERSOMNIA | 3 0.03 49.23 HYPERTENSION | 47 0.47 49.70 HYPERTENSIVE CRISIS | 1 0.01 49.71 HYPERTENSIVE HEART DISEASE | 1 0.01 49.72 HYPERTENSIVE NEPHROPATHY | 1 0.01 49.73 HYPERTHERMIA | 2 0.02 49.75 HYPERTHERMIA MALIGNANT | 2 0.02 49.77 HYPERTHYROIDISM | 4 0.04 49.81 HYPERTONIA | 1 0.01 49.82 HYPERTRIGLYCERIDAEMIA | 1 0.01 49.83 HYPERTROPHY | 1 0.01 49.84 HYPERVENTILATION | 1 0.01 49.85 HYPERVIGILANCE | 1 0.01 49.86 HYPOACUSIS | 3 0.03 49.89 HYPOAESTHESIA | 21 0.21 50.10 HYPOAESTHESIA FACIAL | 2 0.02 50.12 HYPOAESTHESIA ORAL | 4 0.04 50.16 HYPOALBUMINAEMIA | 5 0.05 50.21 HYPOCALCAEMIA | 7 0.07 50.28 HYPOCHROMIC ANAEMIA | 1 0.01 50.29 HYPOGAMMAGLOBULINAEMIA | 1 0.01 50.30 HYPOGEUSIA | 1 0.01 50.31 HYPOGLOSSAL NERVE PARESIS | 1 0.01 50.32 HYPOGLYCAEMIA | 13 0.13 50.45 HYPOGLYCAEMIA UNAWARENESS | 1 0.01 50.46 HYPOGLYCAEMIC SEIZURE | 1 0.01 50.47 HYPOGLYCAEMIC UNCONSCIOUSNESS | 1 0.01 50.48 HYPOKALAEMIA | 12 0.12 50.60 HYPOMAGNESAEMIA | 1 0.01 50.61 HYPOMANIA | 2 0.02 50.63 HYPOMENORRHOEA | 1 0.01 50.64 HYPONATRAEMIA | 17 0.17 50.81 HYPOPARATHYROIDISM | 1 0.01 50.82 HYPOPHAGIA | 5 0.05 50.87 HYPOPHOSPHATAEMIA | 1 0.01 50.88 HYPOPITUITARISM | 1 0.01 50.89 HYPOREFLEXIA | 1 0.01 50.90 HYPOTENSION | 42 0.42 51.32 HYPOTHALAMO-PITUITARY DISORDER | 2 0.02 51.34 HYPOTHERMIA | 3 0.03 51.37 HYPOTHYROIDISM | 5 0.05 51.42 HYPOTONIA | 3 0.03 51.45 HYPOVOLAEMIA | 4 0.04 51.49 HYPOVOLAEMIC SHOCK | 1 0.01 51.50 HYPOXIA | 16 0.16 51.66 HYPOXIC ENCEPHALOPATHY | 1 0.01 51.67 HYSTERECTOMY | 2 0.02 51.69 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 2 0.02 51.71 IIIRD NERVE PARALYSIS | 1 0.01 51.72 IIIRD NERVE PARESIS | 1 0.01 51.73 ILEAL PERFORATION | 1 0.01 51.74 ILEITIS | 4 0.04 51.78 ILEOSTOMY | 1 0.01 51.79 ILEOSTOMY CLOSURE | 1 0.01 51.80 ILEUS | 6 0.06 51.86 ILL-DEFINED DISORDER | 7 0.07 51.93 IMMOBILE | 2 0.02 51.95 IMMUNE RECONSTITUTION SYNDROME | 1 0.01 51.96 IMMUNOSUPPRESSION | 1 0.01 51.97 IMPAIRED DRIVING ABILITY | 4 0.04 52.01 IMPAIRED HEALING | 6 0.06 52.07 IMPAIRED WORK ABILITY | 3 0.03 52.10 IMPETIGO | 2 0.02 52.12 IMPLANT EXPULSION | 1 0.01 52.13 IMPLANT SITE SWELLING | 1 0.01 52.14 IMPLANTABLE DEFIBRILLATOR INSERTION | 1 0.01 52.15 IMPRISONMENT | 1 0.01 52.16 IMPULSIVE BEHAVIOUR | 1 0.01 52.17 INADEQUATE DIET | 2 0.02 52.19 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 1 0.01 52.20 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 6 0.06 52.26 INCISION SITE INFECTION | 1 0.01 52.27 INCISIONAL DRAINAGE | 1 0.01 52.28 INCOHERENT | 2 0.02 52.30 INCONTINENCE | 3 0.03 52.33 INCORRECT DOSE ADMINISTERED | 21 0.21 52.54 INCORRECT DRUG ADMINISTRATION DURATION | 2 0.02 52.56 INCORRECT DRUG ADMINISTRATION RATE | 1 0.01 52.57 INCORRECT ROUTE OF DRUG ADMINISTRATION | 13 0.13 52.70 INCREASED APPETITE | 5 0.05 52.75 INCREASED TENDENCY TO BRUISE | 2 0.02 52.77 INCREASED UPPER AIRWAY SECRETION | 2 0.02 52.79 INFANTILE APNOEIC ATTACK | 1 0.01 52.80 INFARCTION | 1 0.01 52.81 INFECTED CYST | 1 0.01 52.82 INFECTION | 17 0.17 52.99 INFERIOR VENA CAVAL OCCLUSION | 1 0.01 53.00 INFERTILITY FEMALE | 1 0.01 53.01 INFLAMMATION | 5 0.05 53.06 INFLAMMATORY BOWEL DISEASE | 8 0.08 53.14 INFLUENZA | 6 0.06 53.20 INFLUENZA LIKE ILLNESS | 6 0.06 53.26 INFREQUENT BOWEL MOVEMENTS | 1 0.01 53.27 INFUSION RELATED REACTION | 4 0.04 53.31 INFUSION SITE RASH | 1 0.01 53.32 INFUSION SITE REACTION | 1 0.01 53.33 INGROWING NAIL | 1 0.01 53.34 INGUINAL HERNIA | 1 0.01 53.35 INITIAL INSOMNIA | 1 0.01 53.36 INJECTION SITE DISCHARGE | 1 0.01 53.37 INJECTION SITE DISCOLOURATION | 1 0.01 53.38 INJECTION SITE EROSION | 1 0.01 53.39 INJECTION SITE ERYTHEMA | 3 0.03 53.42 INJECTION SITE EXTRAVASATION | 4 0.04 53.46 INJECTION SITE HAEMATOMA | 2 0.02 53.48 INJECTION SITE HAEMORRHAGE | 1 0.01 53.49 INJECTION SITE INDURATION | 2 0.02 53.51 INJECTION SITE INFECTION | 1 0.01 53.52 INJECTION SITE INFLAMMATION | 1 0.01 53.53 INJECTION SITE IRRITATION | 2 0.02 53.55 INJECTION SITE NECROSIS | 1 0.01 53.56 INJECTION SITE NODULE | 1 0.01 53.57 INJECTION SITE PAIN | 3 0.03 53.60 INJECTION SITE PAPULE | 1 0.01 53.61 INJECTION SITE PRURITUS | 1 0.01 53.62 INJECTION SITE RASH | 4 0.04 53.66 INJECTION SITE REACTION | 3 0.03 53.69 INJECTION SITE ULCER | 2 0.02 53.71 INJURY | 29 0.29 54.00 INNER EAR DISORDER | 1 0.01 54.01 INSOMNIA | 41 0.41 54.42 INTENTIONAL DRUG MISUSE | 5 0.05 54.47 INTENTIONAL OVERDOSE | 7 0.07 54.54 INTENTIONAL SELF-INJURY | 3 0.03 54.57 INTERCEPTED DRUG DISPENSING ERROR | 5 0.05 54.62 INTERCOSTAL RETRACTION | 1 0.01 54.63 INTERNATIONAL NORMALISED RATIO FLUCTU.. | 3 0.03 54.66 INTERNATIONAL NORMALISED RATIO INCREA.. | 7 0.07 54.73 INTERSTITIAL LUNG DISEASE | 17 0.17 54.90 INTERVERTEBRAL DISC DEGENERATION | 2 0.02 54.92 INTERVERTEBRAL DISC DISORDER | 2 0.02 54.94 INTERVERTEBRAL DISC OPERATION | 2 0.02 54.96 INTERVERTEBRAL DISC PROTRUSION | 3 0.03 54.99 INTESTINAL ADENOCARCINOMA | 1 0.01 55.00 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 55.01 INTESTINAL HAEMORRHAGE | 2 0.02 55.03 INTESTINAL ISCHAEMIA | 1 0.01 55.04 INTESTINAL OBSTRUCTION | 13 0.13 55.17 INTESTINAL OPERATION | 1 0.01 55.18 INTESTINAL PERFORATION | 6 0.06 55.24 INTESTINAL ULCER | 1 0.01 55.25 INTRA-UTERINE CONTRACEPTIVE DEVICE EX.. | 12 0.12 55.37 INTRA-UTERINE DEATH | 3 0.03 55.40 INTRACARDIAC THROMBUS | 1 0.01 55.41 INTRACRANIAL ANEURYSM | 2 0.02 55.43 INTRACRANIAL HYPOTENSION | 1 0.01 55.44 INTRACRANIAL VENOUS SINUS THROMBOSIS | 3 0.03 55.47 INTRAOCULAR PRESSURE INCREASED | 3 0.03 55.50 INTRAVASCULAR HAEMOLYSIS | 2 0.02 55.52 INTRAVENTRICULAR HAEMORRHAGE | 2 0.02 55.54 INTRAVENTRICULAR HAEMORRHAGE NEONATAL | 1 0.01 55.55 INTUSSUSCEPTION | 1 0.01 55.56 IRIDOCELE | 1 0.01 55.57 IRIDOCYCLITIS | 1 0.01 55.58 IRIS ADHESIONS | 1 0.01 55.59 IRON DEFICIENCY ANAEMIA | 2 0.02 55.61 IRRITABILITY | 16 0.16 55.77 IRRITABLE BOWEL SYNDROME | 5 0.05 55.82 ISCHAEMIA | 3 0.03 55.85 ISCHAEMIC STROKE | 3 0.03 55.88 IUCD COMPLICATION | 18 0.18 56.06 IUD MIGRATION | 6 0.06 56.12 JAUNDICE | 14 0.14 56.26 JAUNDICE CHOLESTATIC | 1 0.01 56.27 JAW DISORDER | 3 0.03 56.30 JEJUNOSTOMY | 1 0.01 56.31 JOINT CONTRACTURE | 2 0.02 56.33 JOINT DISLOCATION | 2 0.02 56.35 JOINT INJURY | 2 0.02 56.37 JOINT RANGE OF MOTION DECREASED | 1 0.01 56.38 JOINT SPRAIN | 1 0.01 56.39 JOINT STIFFNESS | 3 0.03 56.42 JOINT SWELLING | 11 0.11 56.53 KELOID SCAR | 1 0.01 56.54 KERATITIS | 1 0.01 56.55 KERATOCONJUNCTIVITIS SICCA | 1 0.01 56.56 KETOACIDOSIS | 2 0.02 56.58 KIDNEY INFECTION | 3 0.03 56.61 KLEBSIELLA BACTERAEMIA | 1 0.01 56.62 KLEBSIELLA INFECTION | 1 0.01 56.63 KLEBSIELLA SEPSIS | 1 0.01 56.64 KNEE ARTHROPLASTY | 2 0.02 56.66 KNEE OPERATION | 2 0.02 56.68 LABORATORY TEST ABNORMAL | 3 0.03 56.71 LABYRINTHITIS | 2 0.02 56.73 LACERATION | 1 0.01 56.74 LACRIMATION INCREASED | 3 0.03 56.77 LACTIC ACIDOSIS | 5 0.05 56.82 LARGE INTESTINE PERFORATION | 1 0.01 56.83 LARYNGEAL DYSPNOEA | 1 0.01 56.84 LARYNGEAL OEDEMA | 1 0.01 56.85 LARYNGEAL POLYP | 1 0.01 56.86 LARYNGITIS | 2 0.02 56.88 LARYNGOSPASM | 3 0.03 56.91 LEARNING DISABILITY | 1 0.01 56.92 LEFT ATRIAL DILATATION | 1 0.01 56.93 LEFT VENTRICULAR DYSFUNCTION | 1 0.01 56.94 LEFT VENTRICULAR FAILURE | 1 0.01 56.95 LEFT VENTRICULAR HYPERTROPHY | 5 0.05 57.00 LEGIONELLA INFECTION | 1 0.01 57.01 LETHARGY | 19 0.19 57.20 LEUKOCYTOCLASTIC VASCULITIS | 3 0.03 57.23 LEUKOCYTOSIS | 2 0.02 57.25 LEUKOENCEPHALOPATHY | 2 0.02 57.27 LEUKOPENIA | 13 0.13 57.40 LIBIDO DECREASED | 4 0.04 57.44 LIBIDO INCREASED | 1 0.01 57.45 LIGAMENT CALCIFICATION | 1 0.01 57.46 LIGAMENT RUPTURE | 2 0.02 57.48 LIMB DISCOMFORT | 2 0.02 57.50 LIP DRY | 2 0.02 57.52 LIP OEDEMA | 1 0.01 57.53 LIP PAIN | 1 0.01 57.54 LIP SWELLING | 4 0.04 57.58 LIP ULCERATION | 1 0.01 57.59 LIPASE INCREASED | 3 0.03 57.62 LIPODYSTROPHY ACQUIRED | 1 0.01 57.63 LIPOMA | 1 0.01 57.64 LISTERIA SEPSIS | 1 0.01 57.65 LIVEDO RETICULARIS | 1 0.01 57.66 LIVER ABSCESS | 1 0.01 57.67 LIVER DISORDER | 14 0.14 57.81 LIVER FUNCTION TEST ABNORMAL | 17 0.17 57.98 LIVER INJURY | 2 0.02 58.00 LIVER TRANSPLANT REJECTION | 1 0.01 58.01 LOBAR PNEUMONIA | 1 0.01 58.02 LOCAL SWELLING | 2 0.02 58.04 LOCALISED INFECTION | 2 0.02 58.06 LOCALISED OEDEMA | 1 0.01 58.07 LOGORRHOEA | 1 0.01 58.08 LONG QT SYNDROME | 1 0.01 58.09 LOOSE TOOTH | 1 0.01 58.10 LOSS OF CONSCIOUSNESS | 47 0.47 58.57 LOSS OF LIBIDO | 2 0.02 58.59 LOW DENSITY LIPOPROTEIN | 1 0.01 58.60 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 58.62 LUMBAR RADICULOPATHY | 1 0.01 58.63 LUMBAR SPINAL STENOSIS | 1 0.01 58.64 LUMBAR VERTEBRAL FRACTURE | 1 0.01 58.65 LUNG ADENOCARCINOMA | 1 0.01 58.66 LUNG CANCER METASTATIC | 2 0.02 58.68 LUNG DISORDER | 9 0.09 58.77 LUNG INFECTION | 3 0.03 58.80 LUNG INFILTRATION | 6 0.06 58.86 LUNG INJURY | 1 0.01 58.87 LUNG NEOPLASM | 2 0.02 58.89 LUNG NEOPLASM MALIGNANT | 4 0.04 58.93 LUPUS NEPHRITIS | 1 0.01 58.94 LUPUS-LIKE SYNDROME | 1 0.01 58.95 LYMPHADENITIS | 1 0.01 58.96 LYMPHADENOPATHY | 11 0.11 59.07 LYMPHANGITIS | 1 0.01 59.08 LYMPHOCYTE COUNT DECREASED | 1 0.01 59.09 LYMPHOCYTE COUNT INCREASED | 3 0.03 59.12 LYMPHOCYTE MORPHOLOGY ABNORMAL | 1 0.01 59.13 LYMPHOCYTIC INFILTRATION | 1 0.01 59.14 LYMPHOCYTOSIS | 2 0.02 59.16 LYMPHOEDEMA | 1 0.01 59.17 LYMPHOHISTIOCYTOSIS | 1 0.01 59.18 LYMPHOMA | 4 0.04 59.22 LYMPHOPENIA | 2 0.02 59.24 LYMPHOPROLIFERATIVE DISORDER | 1 0.01 59.25 MACULAR DEGENERATION | 4 0.04 59.29 MACULAR OEDEMA | 1 0.01 59.30 MADAROSIS | 1 0.01 59.31 MAJOR DEPRESSION | 4 0.04 59.35 MALABSORPTION | 1 0.01 59.36 MALAISE | 82 0.82 60.18 MALARIA | 1 0.01 60.19 MALIGNANT MELANOMA | 3 0.03 60.22 MALIGNANT NEOPLASM OF PLEURA | 1 0.01 60.23 MALIGNANT NEOPLASM PROGRESSION | 4 0.04 60.27 MALIGNANT URINARY TRACT NEOPLASM | 1 0.01 60.28 MALLORY-WEISS SYNDROME | 1 0.01 60.29 MALNUTRITION | 5 0.05 60.34 MANIA | 10 0.10 60.44 MASS | 3 0.03 60.47 MASTICATION DISORDER | 1 0.01 60.48 MASTITIS | 1 0.01 60.49 MASTOIDITIS | 1 0.01 60.50 MATERNAL DRUGS AFFECTING FOETUS | 2 0.02 60.52 MECHANICAL VENTILATION | 1 0.01 60.53 MECONIUM STAIN | 2 0.02 60.55 MEDICAL DEVICE COMPLICATION | 2 0.02 60.57 MEDICATION ERROR | 56 0.56 61.13 MELAENA | 5 0.05 61.18 MELANOCYTIC NAEVUS | 1 0.01 61.19 MEMORY IMPAIRMENT | 17 0.17 61.36 MENINGITIS | 4 0.04 61.40 MENINGITIS VIRAL | 1 0.01 61.41 MENINGORRHAGIA | 1 0.01 61.42 MENOPAUSAL SYMPTOMS | 1 0.01 61.43 MENOPAUSE | 3 0.03 61.46 MENORRHAGIA | 3 0.03 61.49 MENSTRUAL DISORDER | 1 0.01 61.50 MENSTRUATION DELAYED | 3 0.03 61.53 MENSTRUATION IRREGULAR | 1 0.01 61.54 MENTAL DISORDER | 7 0.07 61.61 MENTAL IMPAIRMENT | 3 0.03 61.64 MENTAL RETARDATION | 1 0.01 61.65 MENTAL STATUS CHANGES | 10 0.10 61.75 METABOLIC ACIDOSIS | 11 0.11 61.86 METABOLIC ENCEPHALOPATHY | 2 0.02 61.88 METASTASES TO BONE | 1 0.01 61.89 METASTASES TO CENTRAL NERVOUS SYSTEM | 1 0.01 61.90 METASTASES TO LIVER | 5 0.05 61.95 METASTASES TO LUNG | 1 0.01 61.96 METASTASES TO LYMPH NODES | 1 0.01 61.97 METASTASIS | 2 0.02 61.99 METASTATIC MALIGNANT MELANOMA | 1 0.01 62.00 METASTATIC NEOPLASM | 1 0.01 62.01 METRORRHAGIA | 1 0.01 62.02 MICROALBUMINURIA | 1 0.01 62.03 MICROANGIOPATHY | 1 0.01 62.04 MICROCYTIC ANAEMIA | 2 0.02 62.06 MIGRAINE | 11 0.11 62.17 MIGRAINE WITH AURA | 2 0.02 62.19 MIOSIS | 1 0.01 62.20 MITOCHONDRIAL DNA MUTATION | 1 0.01 62.21 MITRAL VALVE DISEASE | 2 0.02 62.23 MITRAL VALVE INCOMPETENCE | 4 0.04 62.27 MITRAL VALVE PROLAPSE | 5 0.05 62.32 MITRAL VALVE STENOSIS | 1 0.01 62.33 MOBILITY DECREASED | 11 0.11 62.44 MONOCYTOSIS | 1 0.01 62.45 MOOD ALTERED | 6 0.06 62.51 MOOD SWINGS | 6 0.06 62.57 MOTOR DYSFUNCTION | 2 0.02 62.59 MOUTH HAEMORRHAGE | 1 0.01 62.60 MOUTH INJURY | 2 0.02 62.62 MOUTH ULCERATION | 4 0.04 62.66 MOVEMENT DISORDER | 5 0.05 62.71 MUCOCUTANEOUS RASH | 1 0.01 62.72 MUCOSAL HAEMORRHAGE | 1 0.01 62.73 MUCOSAL INFLAMMATION | 4 0.04 62.77 MULTI-ORGAN DISORDER | 1 0.01 62.78 MULTI-ORGAN FAILURE | 13 0.13 62.91 MULTIPLE CHEMICAL SENSITIVITY | 1 0.01 62.92 MULTIPLE CONGENITAL ABNORMALITIES | 3 0.03 62.95 MULTIPLE DRUG OVERDOSE ACCIDENTAL | 1 0.01 62.96 MULTIPLE DRUG OVERDOSE INTENTIONAL | 2 0.02 62.98 MULTIPLE FRACTURES | 1 0.01 62.99 MULTIPLE MYELOMA | 2 0.02 63.01 MULTIPLE SCLEROSIS | 6 0.06 63.07 MULTIPLE SCLEROSIS RELAPSE | 1 0.01 63.08 MUSCLE ATROPHY | 1 0.01 63.09 MUSCLE CONTRACTIONS INVOLUNTARY | 1 0.01 63.10 MUSCLE CONTRACTURE | 1 0.01 63.11 MUSCLE DISORDER | 1 0.01 63.12 MUSCLE ENZYME INCREASED | 1 0.01 63.13 MUSCLE FATIGUE | 1 0.01 63.14 MUSCLE INJURY | 1 0.01 63.15 MUSCLE RIGIDITY | 1 0.01 63.16 MUSCLE SPASMS | 29 0.29 63.45 MUSCLE STRAIN | 2 0.02 63.47 MUSCLE TIGHTNESS | 3 0.03 63.50 MUSCLE TWITCHING | 3 0.03 63.53 MUSCULAR WEAKNESS | 24 0.24 63.77 MUSCULOSKELETAL CHEST PAIN | 4 0.04 63.81 MUSCULOSKELETAL DISCOMFORT | 1 0.01 63.82 MUSCULOSKELETAL DISORDER | 2 0.02 63.84 MUSCULOSKELETAL PAIN | 10 0.10 63.94 MUSCULOSKELETAL STIFFNESS | 12 0.12 64.06 MYALGIA | 28 0.28 64.34 MYASTHENIA GRAVIS | 2 0.02 64.36 MYCOBACTERIAL INFECTION | 1 0.01 64.37 MYCOBACTERIUM CHELONEI INFECTION | 2 0.02 64.39 MYCOBACTERIUM MARINUM INFECTION | 1 0.01 64.40 MYDRIASIS | 5 0.05 64.45 MYELITIS | 1 0.01 64.46 MYELODYSPLASTIC SYNDROME | 4 0.04 64.50 MYELOFIBROSIS | 1 0.01 64.51 MYOCARDIAL FIBROSIS | 1 0.01 64.52 MYOCARDIAL INFARCTION | 43 0.43 64.95 MYOCARDIAL ISCHAEMIA | 2 0.02 64.97 MYOCLONUS | 6 0.06 65.03 MYODESOPSIA | 1 0.01 65.04 MYOFASCIAL PAIN SYNDROME | 4 0.04 65.08 MYOGLOBIN BLOOD INCREASED | 1 0.01 65.09 MYOGLOBINURIA | 4 0.04 65.13 MYOPATHY | 2 0.02 65.15 MYOSITIS | 3 0.03 65.18 NAIL DISORDER | 1 0.01 65.19 NARCOLEPSY | 1 0.01 65.20 NASAL CONGESTION | 7 0.07 65.27 NASAL DISCOMFORT | 1 0.01 65.28 NASAL OEDEMA | 1 0.01 65.29 NASAL SEPTUM DEVIATION | 1 0.01 65.30 NASOPHARYNGITIS | 6 0.06 65.36 NAUSEA | 102 1.02 66.38 NECK INJURY | 2 0.02 66.40 NECK PAIN | 13 0.13 66.53 NECROSIS | 1 0.01 66.54 NECROTISING COLITIS | 1 0.01 66.55 NEGATIVE THOUGHTS | 1 0.01 66.56 NEONATAL HYPOTENSION | 1 0.01 66.57 NEONATAL RESPIRATORY DISTRESS SYNDROME | 1 0.01 66.58 NEOPLASM | 3 0.03 66.61 NEOPLASM MALIGNANT | 4 0.04 66.65 NEOPLASM PROGRESSION | 5 0.05 66.70 NEPHRITIS INTERSTITIAL | 1 0.01 66.71 NEPHROGENIC DIABETES INSIPIDUS | 1 0.01 66.72 NEPHROGENIC SYSTEMIC FIBROSIS | 6 0.06 66.78 NEPHROLITHIASIS | 12 0.12 66.90 NEPHROPATHY TOXIC | 2 0.02 66.92 NEPHROSCLEROSIS | 1 0.01 66.93 NEPHROTIC SYNDROME | 2 0.02 66.95 NERVE COMPRESSION | 1 0.01 66.96 NERVE INJURY | 2 0.02 66.98 NERVOUS SYSTEM DISORDER | 8 0.08 67.06 NERVOUSNESS | 18 0.18 67.24 NEURALGIA | 7 0.07 67.31 NEURITIS | 1 0.01 67.32 NEUROLEPTIC MALIGNANT SYNDROME | 2 0.02 67.34 NEUROLOGICAL SYMPTOM | 4 0.04 67.38 NEUROMYOPATHY | 1 0.01 67.39 NEUROPATHY PERIPHERAL | 10 0.10 67.49 NEUROSYPHILIS | 1 0.01 67.50 NEUROTOXICITY | 1 0.01 67.51 NEUTROPENIA | 16 0.16 67.67 NEUTROPENIC SEPSIS | 1 0.01 67.68 NEUTROPHIL COUNT DECREASED | 10 0.10 67.78 NEUTROPHIL COUNT INCREASED | 2 0.02 67.80 NIGHT SWEATS | 4 0.04 67.84 NIGHTMARE | 15 0.15 67.99 NO ADVERSE EVENT | 10 0.10 68.09 NO THERAPEUTIC RESPONSE | 3 0.03 68.12 NOCTURIA | 5 0.05 68.17 NOCTURNAL DYSPNOEA | 1 0.01 68.18 NODULE | 1 0.01 68.19 NODULE ON EXTREMITY | 1 0.01 68.20 NON-HODGKIN'S LYMPHOMA | 1 0.01 68.21 NON-HODGKIN'S LYMPHOMA RECURRENT | 1 0.01 68.22 NORMAL NEWBORN | 1 0.01 68.23 NORMOCHROMIC NORMOCYTIC ANAEMIA | 1 0.01 68.24 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 1 0.01 68.25 OBESITY | 3 0.03 68.28 OBLITERATIVE BRONCHIOLITIS | 1 0.01 68.29 OBSESSIVE THOUGHTS | 1 0.01 68.30 OBSESSIVE-COMPULSIVE DISORDER | 8 0.08 68.38 OBSTRUCTION GASTRIC | 1 0.01 68.39 OBSTRUCTIVE AIRWAYS DISORDER | 3 0.03 68.42 OCULAR HYPERAEMIA | 5 0.05 68.47 OCULAR ICTERUS | 2 0.02 68.49 OEDEMA | 10 0.10 68.59 OEDEMA MOUTH | 6 0.06 68.65 OEDEMA PERIPHERAL | 39 0.39 69.04 OESOPHAGEAL CARCINOMA | 2 0.02 69.06 OESOPHAGEAL FISTULA | 1 0.01 69.07 OESOPHAGEAL NEOPLASM | 1 0.01 69.08 OESOPHAGEAL RUPTURE | 1 0.01 69.09 OESOPHAGEAL SPASM | 1 0.01 69.10 OESOPHAGITIS | 3 0.03 69.13 OESTROGEN RECEPTOR ASSAY POSITIVE | 1 0.01 69.14 OFF LABEL USE | 6 0.06 69.20 OLIGOHYDRAMNIOS | 1 0.01 69.21 OLIGOMENORRHOEA | 1 0.01 69.22 OLIGURIA | 1 0.01 69.23 OPEN WOUND | 1 0.01 69.24 OPERATIVE HAEMORRHAGE | 1 0.01 69.25 OPHTHALMOLOGICAL EXAMINATION ABNORMAL | 1 0.01 69.26 OPISTHOTONUS | 1 0.01 69.27 OPTIC ISCHAEMIC NEUROPATHY | 1 0.01 69.28 OPTIC NEURITIS | 1 0.01 69.29 OPTIC NEUROPATHY | 1 0.01 69.30 ORAL CANDIDIASIS | 2 0.02 69.32 ORAL DISCOMFORT | 3 0.03 69.35 ORAL DISORDER | 3 0.03 69.38 ORAL FIBROMA | 1 0.01 69.39 ORAL HERPES | 4 0.04 69.43 ORAL INFECTION | 8 0.08 69.51 ORAL PAIN | 5 0.05 69.56 ORAL SURGERY | 2 0.02 69.58 ORAL TORUS | 2 0.02 69.60 ORGAN FAILURE | 3 0.03 69.63 ORGANISING PNEUMONIA | 8 0.08 69.71 OROPHARYNGEAL BLISTERING | 1 0.01 69.72 OROPHARYNGEAL DISCOMFORT | 1 0.01 69.73 OROPHARYNGEAL PAIN | 14 0.14 69.87 ORTHOPNOEA | 2 0.02 69.89 ORTHOSTATIC HYPOTENSION | 2 0.02 69.91 OSTEITIS | 1 0.01 69.92 OSTEOARTHRITIS | 7 0.07 69.99 OSTEOMYELITIS | 13 0.13 70.12 OSTEOMYELITIS ACUTE | 1 0.01 70.13 OSTEOMYELITIS CHRONIC | 2 0.02 70.15 OSTEOMYELITIS DRAINAGE | 1 0.01 70.16 OSTEONECROSIS | 58 0.58 70.74 OSTEOPENIA | 9 0.09 70.83 OSTEOPOROSIS | 4 0.04 70.87 OSTEOPOROTIC FRACTURE | 1 0.01 70.88 OTITIS EXTERNA | 2 0.02 70.90 OTITIS MEDIA | 3 0.03 70.93 OTITIS MEDIA CHRONIC | 1 0.01 70.94 OTORRHOEA | 1 0.01 70.95 OTOTOXICITY | 1 0.01 70.96 OVARIAN CANCER | 2 0.02 70.98 OVARIAN CYST | 6 0.06 71.04 OVARIAN ENLARGEMENT | 1 0.01 71.05 OVERDOSE | 25 0.25 71.30 OXYGEN SATURATION DECREASED | 9 0.09 71.39 PAIN | 65 0.65 72.04 PAIN IN EXTREMITY | 31 0.31 72.35 PAIN IN JAW | 6 0.06 72.41 PAIN OF SKIN | 1 0.01 72.42 PAINFUL RESPIRATION | 1 0.01 72.43 PALLOR | 7 0.07 72.50 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 4 0.04 72.54 PALPITATIONS | 30 0.30 72.84 PANCREATIC CARCINOMA | 2 0.02 72.86 PANCREATIC CYST | 1 0.01 72.87 PANCREATIC DISORDER | 2 0.02 72.89 PANCREATIC INSUFFICIENCY | 1 0.01 72.90 PANCREATITIS | 15 0.15 73.05 PANCREATITIS ACUTE | 4 0.04 73.09 PANCREATITIS NECROTISING | 1 0.01 73.10 PANCYTOPENIA | 17 0.17 73.27 PANIC ATTACK | 17 0.17 73.44 PANIC DISORDER | 1 0.01 73.45 PANIC REACTION | 4 0.04 73.49 PAPILLARY TUMOUR OF RENAL PELVIS | 1 0.01 73.50 PAPILLOEDEMA | 1 0.01 73.51 PARADOXICAL DRUG REACTION | 2 0.02 73.53 PARADOXICAL PAIN | 1 0.01 73.54 PARAESTHESIA | 24 0.24 73.78 PARAESTHESIA ORAL | 1 0.01 73.79 PARALYSIS | 6 0.06 73.85 PARANOIA | 4 0.04 73.89 PARAPARESIS | 1 0.01 73.90 PARATHYROID DISORDER | 1 0.01 73.91 PARATHYROIDECTOMY | 2 0.02 73.93 PARESIS | 2 0.02 73.95 PARKINSONISM | 3 0.03 73.98 PAROSMIA | 2 0.02 74.00 PAROTITIS | 1 0.01 74.01 PATELLA FRACTURE | 1 0.01 74.02 PATENT DUCTUS ARTERIOSUS | 6 0.06 74.08 PATERNAL DRUGS AFFECTING FOETUS | 1 0.01 74.09 PATHOLOGICAL FRACTURE | 1 0.01 74.10 PATHOLOGICAL GAMBLING | 16 0.16 74.26 PELVIC ABSCESS | 1 0.01 74.27 PELVIC FLUID COLLECTION | 1 0.01 74.28 PELVIC FRACTURE | 5 0.05 74.33 PELVIC INFLAMMATORY DISEASE | 2 0.02 74.35 PELVIC MASS | 1 0.01 74.36 PELVIC PAIN | 10 0.10 74.46 PELVIC VENOUS THROMBOSIS | 1 0.01 74.47 PEMPHIGOID | 1 0.01 74.48 PENILE SWELLING | 1 0.01 74.49 PENIS DISORDER | 1 0.01 74.50 PEPTIC ULCER | 2 0.02 74.52 PERFORMANCE STATUS DECREASED | 2 0.02 74.54 PERICARDIAL EFFUSION | 7 0.07 74.61 PERICARDIAL HAEMORRHAGE | 1 0.01 74.62 PERICARDITIS | 1 0.01 74.63 PERIODONTAL DISEASE | 1 0.01 74.64 PERIPHERAL COLDNESS | 2 0.02 74.66 PERIPHERAL ISCHAEMIA | 6 0.06 74.72 PERIPHERAL NERVE OPERATION | 1 0.01 74.73 PERIPHERAL VASCULAR DISORDER | 1 0.01 74.74 PERIRECTAL ABSCESS | 1 0.01 74.75 PERITONEAL CARCINOMA | 1 0.01 74.76 PERITONEAL DIALYSIS COMPLICATION | 1 0.01 74.77 PERITONEAL EFFUSION | 2 0.02 74.79 PERITONEAL HAEMORRHAGE | 1 0.01 74.80 PERITONEAL INFECTION | 1 0.01 74.81 PERITONEAL TUBERCULOSIS | 1 0.01 74.82 PERITONITIS | 7 0.07 74.89 PERITONITIS BACTERIAL | 1 0.01 74.90 PERIVASCULAR DERMATITIS | 1 0.01 74.91 PERONEAL NERVE PALSY | 1 0.01 74.92 PERSECUTORY DELUSION | 1 0.01 74.93 PERSISTENT FOETAL CIRCULATION | 3 0.03 74.96 PERSONALITY CHANGE | 3 0.03 74.99 PERSONALITY DISORDER | 1 0.01 75.00 PETECHIAE | 2 0.02 75.02 PHARMACEUTICAL PRODUCT COMPLAINT | 38 0.38 75.40 PHARMACEUTICAL PRODUCT COUNTERFEIT | 2 0.02 75.42 PHARYNGEAL DISORDER | 2 0.02 75.44 PHARYNGEAL OEDEMA | 6 0.06 75.50 PHARYNGITIS | 3 0.03 75.53 PHARYNGOESOPHAGEAL DIVERTICULUM | 1 0.01 75.54 PHLEBITIS | 6 0.06 75.60 PHOTOPHOBIA | 2 0.02 75.62 PHOTOPSIA | 1 0.01 75.63 PHOTOSENSITIVITY REACTION | 5 0.05 75.68 PHYSICAL ASSAULT | 2 0.02 75.70 PIGMENTATION DISORDER | 1 0.01 75.71 PINEAL NEOPLASM | 1 0.01 75.72 PITUITARY HAEMORRHAGE | 1 0.01 75.73 PITUITARY TUMOUR | 2 0.02 75.75 PLACENTA PRAEVIA | 1 0.01 75.76 PLACENTAL INFARCTION | 1 0.01 75.77 PLACENTAL INSUFFICIENCY | 1 0.01 75.78 PLANTAR FASCIITIS | 1 0.01 75.79 PLASMACYTOSIS | 1 0.01 75.80 PLASMODIUM FALCIPARUM INFECTION | 2 0.02 75.82 PLATELET COUNT | 1 0.01 75.83 PLATELET COUNT DECREASED | 17 0.17 76.00 PLATELET COUNT INCREASED | 2 0.02 76.02 PLEURAL EFFUSION | 24 0.24 76.26 PLEURAL FIBROSIS | 1 0.01 76.27 PLEURAL HAEMORRHAGE | 1 0.01 76.28 PLEURISY | 5 0.05 76.33 PLEURITIC PAIN | 1 0.01 76.34 PNEUMATOSIS INTESTINALIS | 2 0.02 76.36 PNEUMOCYSTIS JIROVECI PNEUMONIA | 5 0.05 76.41 PNEUMONIA | 59 0.59 77.00 PNEUMONIA ASPIRATION | 1 0.01 77.01 PNEUMONIA CRYPTOCOCCAL | 1 0.01 77.02 PNEUMONIA CYTOMEGALOVIRAL | 1 0.01 77.03 PNEUMONIA FUNGAL | 1 0.01 77.04 PNEUMONIA LEGIONELLA | 2 0.02 77.06 PNEUMONIA MYCOPLASMAL | 1 0.01 77.07 PNEUMONIA STREPTOCOCCAL | 1 0.01 77.08 PNEUMONITIS | 7 0.07 77.15 PNEUMOTHORAX | 1 0.01 77.16 PO2 DECREASED | 1 0.01 77.17 POISONING | 1 0.01 77.18 POLLAKIURIA | 7 0.07 77.25 POLYCYTHAEMIA | 1 0.01 77.26 POLYDIPSIA | 1 0.01 77.27 POLYHYDRAMNIOS | 1 0.01 77.28 POLYMENORRHOEA | 1 0.01 77.29 POLYMYOSITIS | 1 0.01 77.30 POLYNEUROPATHY | 3 0.03 77.33 POLYP | 2 0.02 77.35 POOR QUALITY DRUG ADMINISTERED | 1 0.01 77.36 POOR QUALITY SLEEP | 4 0.04 77.40 PORTAL HYPERTENSION | 1 0.01 77.41 POST HERPETIC NEURALGIA | 2 0.02 77.43 POST PROCEDURAL COMPLICATION | 4 0.04 77.47 POST PROCEDURAL DISCOMFORT | 2 0.02 77.49 POST PROCEDURAL HAEMATOMA | 1 0.01 77.50 POST PROCEDURAL HAEMORRHAGE | 4 0.04 77.54 POST PROCEDURAL INFECTION | 1 0.01 77.55 POST-TRAUMATIC STRESS DISORDER | 1 0.01 77.56 POSTOPERATIVE WOUND INFECTION | 1 0.01 77.57 POTENTIATING DRUG INTERACTION | 1 0.01 77.58 PRE-ECLAMPSIA | 3 0.03 77.61 PREALBUMIN DECREASED | 1 0.01 77.62 PRECANCEROUS SKIN LESION | 1 0.01 77.63 PREGNANCY | 10 0.10 77.73 PREGNANCY TEST URINE POSITIVE | 1 0.01 77.74 PREGNANCY WITH CONTRACEPTIVE DEVICE | 9 0.09 77.83 PREGNANCY WITH IMPLANT CONTRACEPTIVE | 1 0.01 77.84 PREMATURE BABY | 4 0.04 77.88 PREMATURE LABOUR | 1 0.01 77.89 PRESYNCOPE | 3 0.03 77.92 PROCEDURAL PAIN | 4 0.04 77.96 PROCTITIS | 2 0.02 77.98 PRODUCTIVE COUGH | 3 0.03 78.01 PROGESTERONE RECEPTOR ASSAY POSITIVE | 1 0.01 78.02 PROGRESSIVE MULTIPLE SCLEROSIS | 1 0.01 78.03 PROPOFOL INFUSION SYNDROME | 5 0.05 78.08 PROSTATE CANCER | 6 0.06 78.14 PROSTATE CANCER METASTATIC | 1 0.01 78.15 PROSTATE CANCER STAGE IV | 1 0.01 78.16 PROSTATE INFECTION | 1 0.01 78.17 PROSTATIC CALCIFICATION | 1 0.01 78.18 PROSTATIC PAIN | 1 0.01 78.19 PROSTATIC SPECIFIC ANTIGEN INCREASED | 5 0.05 78.24 PROTEIN TOTAL DECREASED | 1 0.01 78.25 PROTEIN URINE PRESENT | 1 0.01 78.26 PROTEINURIA | 5 0.05 78.31 PROTHROMBIN TIME PROLONGED | 4 0.04 78.35 PROTHROMBIN TIME SHORTENED | 1 0.01 78.36 PRURITUS | 37 0.37 78.73 PRURITUS GENERALISED | 6 0.06 78.79 PSEUDARTHROSIS | 1 0.01 78.80 PSEUDOLYMPHOMA | 1 0.01 78.81 PSEUDOMONAL SEPSIS | 1 0.01 78.82 PSEUDOMONAS INFECTION | 1 0.01 78.83 PSEUDOPOLYP | 1 0.01 78.84 PSEUDOPOLYPOSIS | 1 0.01 78.85 PSORIASIS | 5 0.05 78.90 PSORIATIC ARTHROPATHY | 1 0.01 78.91 PSYCHIATRIC SYMPTOM | 1 0.01 78.92 PSYCHOMOTOR HYPERACTIVITY | 1 0.01 78.93 PSYCHOMOTOR RETARDATION | 1 0.01 78.94 PSYCHOMOTOR SKILLS IMPAIRED | 1 0.01 78.95 PSYCHOTIC BEHAVIOUR | 1 0.01 78.96 PSYCHOTIC DISORDER | 14 0.14 79.10 PULMONARY ARTERY STENOSIS | 1 0.01 79.11 PULMONARY ARTERY STENOSIS CONGENITAL | 2 0.02 79.13 PULMONARY CONGESTION | 3 0.03 79.16 PULMONARY EMBOLISM | 25 0.25 79.41 PULMONARY FIBROSIS | 1 0.01 79.42 PULMONARY HAEMORRHAGE | 1 0.01 79.43 PULMONARY HYPERTENSION | 2 0.02 79.45 PULMONARY HYPOPLASIA | 1 0.01 79.46 PULMONARY MASS | 1 0.01 79.47 PULMONARY OEDEMA | 10 0.10 79.57 PULMONARY THROMBOSIS | 1 0.01 79.58 PULMONARY TOXICITY | 2 0.02 79.60 PULMONARY VALVE STENOSIS | 3 0.03 79.63 PULMONARY VALVE STENOSIS CONGENITAL | 1 0.01 79.64 PULMONARY VENO-OCCLUSIVE DISEASE | 1 0.01 79.65 PULSE ABSENT | 3 0.03 79.68 PULSE PRESSURE DECREASED | 1 0.01 79.69 PUNCTATE KERATITIS | 1 0.01 79.70 PURPURA | 3 0.03 79.73 PURULENCE | 1 0.01 79.74 PURULENT DISCHARGE | 2 0.02 79.76 PUSTULAR PSORIASIS | 1 0.01 79.77 PYELONEPHRITIS | 4 0.04 79.81 PYODERMA GANGRENOSUM | 3 0.03 79.84 PYREXIA | 80 0.80 80.64 PYURIA | 1 0.01 80.65 QUALITY OF LIFE DECREASED | 1 0.01 80.66 RADIATION OESOPHAGITIS | 1 0.01 80.67 RADIATION SKIN INJURY | 1 0.01 80.68 RADICULITIS | 1 0.01 80.69 RADICULOPATHY | 1 0.01 80.70 RADIOTHERAPY | 1 0.01 80.71 RALES | 1 0.01 80.72 RASH | 43 0.43 81.15 RASH ERYTHEMATOUS | 6 0.06 81.21 RASH GENERALISED | 14 0.14 81.35 RASH MACULAR | 4 0.04 81.39 RASH MACULO-PAPULAR | 1 0.01 81.40 RASH MORBILLIFORM | 1 0.01 81.41 RASH PAPULAR | 3 0.03 81.44 RASH PRURITIC | 3 0.03 81.47 RASH PUSTULAR | 1 0.01 81.48 RASH VESICULAR | 1 0.01 81.49 RAYNAUD'S PHENOMENON | 3 0.03 81.52 REACTION TO DRUG EXCIPIENTS | 3 0.03 81.55 REACTION TO PRESERVATIVES | 1 0.01 81.56 READING DISORDER | 2 0.02 81.58 RECALL PHENOMENON | 1 0.01 81.59 RECTAL CANCER | 2 0.02 81.61 RECTAL FISSURE | 1 0.01 81.62 RECTAL HAEMORRHAGE | 16 0.16 81.78 RECTOCELE REPAIR | 1 0.01 81.79 RECURRENT CANCER | 1 0.01 81.80 RED BLOOD CELL COUNT DECREASED | 4 0.04 81.84 RED BLOOD CELL MORPHOLOGY ABNORMAL | 1 0.01 81.85 REFLUX OESOPHAGITIS | 1 0.01 81.86 REFUSAL OF TREATMENT BY PATIENT | 2 0.02 81.88 REFUSAL OF TREATMENT BY RELATIVE | 1 0.01 81.89 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 1 0.01 81.90 REMOVAL OF TRANSPLANTED ORGAN | 1 0.01 81.91 RENAL APLASIA | 2 0.02 81.93 RENAL CELL CARCINOMA | 3 0.03 81.96 RENAL COLIC | 1 0.01 81.97 RENAL CYST | 2 0.02 81.99 RENAL DISORDER | 6 0.06 82.05 RENAL FAILURE | 42 0.42 82.47 RENAL FAILURE ACUTE | 37 0.37 82.84 RENAL FAILURE CHRONIC | 5 0.05 82.89 RENAL IMPAIRMENT | 9 0.09 82.98 RENAL MASS | 1 0.01 82.99 RENAL NEOPLASM | 1 0.01 83.00 RENAL PAIN | 7 0.07 83.07 RENAL TRANSPLANT | 1 0.01 83.08 RENAL TUBULAR ACIDOSIS | 1 0.01 83.09 RENAL TUBULAR DISORDER | 1 0.01 83.10 RENAL TUBULAR NECROSIS | 1 0.01 83.11 RESIDUAL URINE | 1 0.01 83.12 RESORPTION BONE INCREASED | 6 0.06 83.18 RESPIRATION ABNORMAL | 1 0.01 83.19 RESPIRATORY ACIDOSIS | 1 0.01 83.20 RESPIRATORY ALKALOSIS | 1 0.01 83.21 RESPIRATORY ARREST | 3 0.03 83.24 RESPIRATORY DEPRESSION | 2 0.02 83.26 RESPIRATORY DISORDER | 6 0.06 83.32 RESPIRATORY DISTRESS | 16 0.16 83.48 RESPIRATORY FAILURE | 22 0.22 83.70 RESPIRATORY RATE INCREASED | 2 0.02 83.72 RESPIRATORY TRACT CONGESTION | 1 0.01 83.73 RESPIRATORY TRACT INFECTION | 1 0.01 83.74 RESTLESS LEGS SYNDROME | 1 0.01 83.75 RESTLESSNESS | 11 0.11 83.86 RETCHING | 5 0.05 83.91 RETINAL ARTERY OCCLUSION | 1 0.01 83.92 RETINAL DEGENERATION | 1 0.01 83.93 RETINAL DETACHMENT | 4 0.04 83.97 RETINAL DISORDER | 3 0.03 84.00 RETINAL ISCHAEMIA | 2 0.02 84.02 RETINAL TEAR | 2 0.02 84.04 RETINAL VASCULAR THROMBOSIS | 1 0.01 84.05 RETROPERITONEAL HAEMATOMA | 1 0.01 84.06 RETROPERITONEAL HAEMORRHAGE | 1 0.01 84.07 RHABDOMYOLYSIS | 24 0.24 84.31 RHEUMATIC FEVER | 1 0.01 84.32 RHEUMATOID ARTHRITIS | 7 0.07 84.39 RHEUMATOID NODULE | 2 0.02 84.41 RHINITIS | 2 0.02 84.43 RHINITIS ALLERGIC | 3 0.03 84.46 RHINORRHOEA | 7 0.07 84.53 RHONCHI | 1 0.01 84.54 RIB FRACTURE | 8 0.08 84.62 RIGHT VENTRICULAR FAILURE | 1 0.01 84.63 RIGHT VENTRICULAR HYPERTROPHY | 2 0.02 84.65 ROAD TRAFFIC ACCIDENT | 10 0.10 84.75 ROTATOR CUFF REPAIR | 1 0.01 84.76 ROTATOR CUFF SYNDROME | 5 0.05 84.81 ROTAVIRUS INFECTION | 1 0.01 84.82 RUPTURED CEREBRAL ANEURYSM | 1 0.01 84.83 RUPTURED ECTOPIC PREGNANCY | 2 0.02 84.85 SACCADIC EYE MOVEMENT | 1 0.01 84.86 SALIVARY GLAND NEOPLASM | 1 0.01 84.87 SALIVARY HYPERSECRETION | 2 0.02 84.89 SALPINGECTOMY | 1 0.01 84.90 SARCOIDOSIS | 1 0.01 84.91 SCAB | 1 0.01 84.92 SCAR | 6 0.06 84.98 SCHIZOID PERSONALITY DISORDER | 1 0.01 84.99 SCHIZOPHRENIA | 4 0.04 85.03 SCHIZOPHRENIA, PARANOID TYPE | 1 0.01 85.04 SCIATICA | 2 0.02 85.06 SCLERODERMA | 1 0.01 85.07 SCOLIOSIS | 1 0.01 85.08 SCOTOMA | 1 0.01 85.09 SCREAMING | 2 0.02 85.11 SCROTAL SWELLING | 1 0.01 85.12 SECRETION DISCHARGE | 1 0.01 85.13 SEDATION | 5 0.05 85.18 SELF-INJURIOUS IDEATION | 1 0.01 85.19 SELF-MEDICATION | 2 0.02 85.21 SEMEN VOLUME DECREASED | 1 0.01 85.22 SENSATION OF HEAVINESS | 3 0.03 85.25 SENSORY DISTURBANCE | 6 0.06 85.31 SENSORY LOSS | 1 0.01 85.32 SEPSIS | 27 0.27 85.59 SEPTIC SHOCK | 9 0.09 85.68 SEQUESTRECTOMY | 1 0.01 85.69 SEROMA | 2 0.02 85.71 SEROTONIN SYNDROME | 3 0.03 85.74 SERUM SEROTONIN INCREASED | 1 0.01 85.75 SERUM SICKNESS | 2 0.02 85.77 SEXUAL ABUSE | 1 0.01 85.78 SEXUAL DYSFUNCTION | 1 0.01 85.79 SHOCK | 10 0.10 85.89 SHOCK HAEMORRHAGIC | 1 0.01 85.90 SHONE COMPLEX | 1 0.01 85.91 SHORT-BOWEL SYNDROME | 1 0.01 85.92 SIALOADENITIS | 1 0.01 85.93 SINUS DISORDER | 7 0.07 86.00 SINUS TACHYCARDIA | 4 0.04 86.04 SINUSITIS | 9 0.09 86.13 SINUSITIS ASPERGILLUS | 1 0.01 86.14 SJOGREN'S SYNDROME | 1 0.01 86.15 SKELETAL INJURY | 1 0.01 86.16 SKIN BACTERIAL INFECTION | 1 0.01 86.17 SKIN CANCER | 6 0.06 86.23 SKIN DISCOLOURATION | 2 0.02 86.25 SKIN DISORDER | 6 0.06 86.31 SKIN EXFOLIATION | 7 0.07 86.38 SKIN FIBROSIS | 4 0.04 86.42 SKIN HAEMORRHAGE | 1 0.01 86.43 SKIN HYPERTROPHY | 1 0.01 86.44 SKIN INDURATION | 1 0.01 86.45 SKIN INFLAMMATION | 1 0.01 86.46 SKIN INJURY | 2 0.02 86.48 SKIN IRRITATION | 1 0.01 86.49 SKIN LACERATION | 1 0.01 86.50 SKIN LESION | 5 0.05 86.55 SKIN NECROSIS | 3 0.03 86.58 SKIN ODOUR ABNORMAL | 3 0.03 86.61 SKIN TOXICITY | 1 0.01 86.62 SKIN ULCER | 6 0.06 86.68 SKIN WARM | 2 0.02 86.70 SKIN WRINKLING | 1 0.01 86.71 SKULL FRACTURE | 1 0.01 86.72 SLEEP APNOEA SYNDROME | 2 0.02 86.74 SLEEP DISORDER | 9 0.09 86.83 SLEEP PHASE RHYTHM DISTURBANCE | 1 0.01 86.84 SLEEP TALKING | 1 0.01 86.85 SMALL CELL CARCINOMA | 1 0.01 86.86 SMALL CELL LUNG CANCER METASTATIC | 1 0.01 86.87 SMALL INTESTINAL OBSTRUCTION | 3 0.03 86.90 SMALL INTESTINAL PERFORATION | 2 0.02 86.92 SMALL INTESTINAL RESECTION | 1 0.01 86.93 SMALL INTESTINE GANGRENE | 1 0.01 86.94 SNEEZING | 6 0.06 87.00 SOCIAL PHOBIA | 1 0.01 87.01 SOCIAL PROBLEM | 1 0.01 87.02 SOFT TISSUE INJURY | 1 0.01 87.03 SOMNAMBULISM | 2 0.02 87.05 SOMNOLENCE | 39 0.39 87.44 SPEECH DISORDER | 9 0.09 87.53 SPINAL COLUMN STENOSIS | 4 0.04 87.57 SPINAL COMPRESSION FRACTURE | 1 0.01 87.58 SPINAL CORD COMPRESSION | 2 0.02 87.60 SPINAL CORD DISORDER | 1 0.01 87.61 SPINAL CORD INJURY | 1 0.01 87.62 SPINAL CORD OEDEMA | 1 0.01 87.63 SPINAL DISORDER | 2 0.02 87.65 SPINAL FRACTURE | 1 0.01 87.66 SPINAL MYELOGRAM ABNORMAL | 1 0.01 87.67 SPINAL OPERATION | 1 0.01 87.68 SPINAL OSTEOARTHRITIS | 1 0.01 87.69 SPINAL X-RAY ABNORMAL | 1 0.01 87.70 SPLEEN DISORDER | 1 0.01 87.71 SPLENECTOMY | 2 0.02 87.73 SPLENIC INFARCTION | 1 0.01 87.74 SPLENOMEGALY | 3 0.03 87.77 SPONDYLITIS | 1 0.01 87.78 SPONDYLOLISTHESIS | 3 0.03 87.81 SQUAMOUS CELL CARCINOMA | 3 0.03 87.84 STAPHYLOCOCCAL BACTERAEMIA | 4 0.04 87.88 STAPHYLOCOCCAL INFECTION | 6 0.06 87.94 STAPHYLOCOCCAL SEPSIS | 3 0.03 87.97 STATUS EPILEPTICUS | 3 0.03 88.00 STATUS MIGRAINOSUS | 1 0.01 88.01 STEATORRHOEA | 1 0.01 88.02 STEM CELL TRANSPLANT | 1 0.01 88.03 STENT PLACEMENT | 3 0.03 88.06 STEVENS-JOHNSON SYNDROME | 4 0.04 88.10 STITCH ABSCESS | 1 0.01 88.11 STOMACH DISCOMFORT | 5 0.05 88.16 STOMATITIS | 12 0.12 88.28 STRABISMUS | 2 0.02 88.30 STREPTOCOCCAL BACTERAEMIA | 1 0.01 88.31 STRESS | 14 0.14 88.45 STRESS CARDIOMYOPATHY | 1 0.01 88.46 STRESS FRACTURE | 1 0.01 88.47 STRIDOR | 2 0.02 88.49 STRONGYLOIDIASIS | 2 0.02 88.51 STUPOR | 2 0.02 88.53 SUBARACHNOID HAEMORRHAGE | 4 0.04 88.57 SUBARACHNOID HAEMORRHAGE NEONATAL | 1 0.01 88.58 SUBDIAPHRAGMATIC ABSCESS | 1 0.01 88.59 SUBDURAL HAEMATOMA | 3 0.03 88.62 SUBDURAL HAEMORRHAGE | 2 0.02 88.64 SUBMANDIBULAR MASS | 1 0.01 88.65 SUBSTANCE ABUSE | 3 0.03 88.68 SUDDEN CARDIAC DEATH | 3 0.03 88.71 SUDDEN DEATH | 8 0.08 88.79 SUDDEN INFANT DEATH SYNDROME | 1 0.01 88.80 SUDDEN ONSET OF SLEEP | 1 0.01 88.81 SUFFOCATION FEELING | 1 0.01 88.82 SUICIDAL BEHAVIOUR | 2 0.02 88.84 SUICIDAL IDEATION | 36 0.36 89.20 SUICIDE ATTEMPT | 20 0.20 89.40 SUPERIOR SAGITTAL SINUS THROMBOSIS | 2 0.02 89.42 SUPRAVENTRICULAR EXTRASYSTOLES | 1 0.01 89.43 SUPRAVENTRICULAR TACHYCARDIA | 6 0.06 89.49 SURGERY | 13 0.13 89.62 SURGICAL PROCEDURE REPEATED | 1 0.01 89.63 SWELLING | 16 0.16 89.79 SWELLING FACE | 12 0.12 89.91 SWOLLEN TONGUE | 1 0.01 89.92 SYNCOPE | 29 0.29 90.21 SYNCOPE VASOVAGAL | 3 0.03 90.24 SYNOVIAL CYST | 2 0.02 90.26 SYNOVITIS | 3 0.03 90.29 SYSTEMIC LUPUS ERYTHEMATOSUS | 4 0.04 90.33 T-CELL LYMPHOMA | 1 0.01 90.34 TACHYCARDIA | 23 0.23 90.57 TACHYPNOEA | 2 0.02 90.59 TALIPES | 2 0.02 90.61 TARDIVE DYSKINESIA | 2 0.02 90.63 TEARFULNESS | 4 0.04 90.67 TEMPORAL ARTERITIS | 1 0.01 90.68 TEMPOROMANDIBULAR JOINT SYNDROME | 8 0.08 90.76 TENDERNESS | 2 0.02 90.78 TENDON CALCIFICATION | 1 0.01 90.79 TENDON DISORDER | 3 0.03 90.82 TENDON INJURY | 1 0.01 90.83 TENDON OPERATION | 1 0.01 90.84 TENDON PAIN | 3 0.03 90.87 TENDON RUPTURE | 1 0.01 90.88 TENDON SHEATH INCISION | 1 0.01 90.89 TENDONITIS | 8 0.08 90.97 TENOSYNOVITIS | 1 0.01 90.98 TENSION | 1 0.01 90.99 TESTIS CANCER | 1 0.01 91.00 THERAPEUTIC AGENT TOXICITY | 9 0.09 91.09 THERAPEUTIC PRODUCT CONTAMINATION | 1 0.01 91.10 THERAPEUTIC RESPONSE DECREASED | 6 0.06 91.16 THERAPEUTIC RESPONSE UNEXPECTED | 3 0.03 91.19 THERAPEUTIC RESPONSE UNEXPECTED WITH .. | 9 0.09 91.28 THERMAL BURN | 4 0.04 91.32 THINKING ABNORMAL | 6 0.06 91.38 THIRST | 2 0.02 91.40 THROAT IRRITATION | 2 0.02 91.42 THROAT TIGHTNESS | 6 0.06 91.48 THROMBOCYTHAEMIA | 1 0.01 91.49 THROMBOCYTOPENIA | 34 0.34 91.83 THROMBOCYTOPENIC PURPURA | 1 0.01 91.84 THROMBOPHLEBITIS | 2 0.02 91.86 THROMBOPHLEBITIS SEPTIC | 1 0.01 91.87 THROMBOSIS | 13 0.13 92.00 THROMBOTIC MICROANGIOPATHY | 1 0.01 92.01 THROMBOTIC THROMBOCYTOPENIC PURPURA | 1 0.01 92.02 THYROID CANCER | 2 0.02 92.04 THYROID CYST | 1 0.01 92.05 THYROID DISORDER | 2 0.02 92.07 THYROID FUNCTION TEST ABNORMAL | 3 0.03 92.10 THYROID NEOPLASM | 1 0.01 92.11 THYROIDECTOMY | 1 0.01 92.12 TIC | 1 0.01 92.13 TINNITUS | 8 0.08 92.21 TOBACCO ABUSE | 1 0.01 92.22 TOBACCO USER | 2 0.02 92.24 TOE AMPUTATION | 2 0.02 92.26 TONGUE BITING | 2 0.02 92.28 TONGUE COATED | 1 0.01 92.29 TONGUE DISORDER | 1 0.01 92.30 TONGUE NEOPLASM MALIGNANT STAGE UNSPE.. | 1 0.01 92.31 TONGUE ULCERATION | 3 0.03 92.34 TONSILLITIS | 1 0.01 92.35 TOOTH ABSCESS | 6 0.06 92.41 TOOTH DISORDER | 3 0.03 92.44 TOOTH EXTRACTION | 2 0.02 92.46 TOOTH FRACTURE | 3 0.03 92.49 TOOTH IMPACTED | 1 0.01 92.50 TOOTH LOSS | 6 0.06 92.56 TOOTH MALFORMATION | 1 0.01 92.57 TOOTHACHE | 4 0.04 92.61 TORSADE DE POINTES | 3 0.03 92.64 TOTAL LUNG CAPACITY DECREASED | 2 0.02 92.66 TOXIC EPIDERMAL NECROLYSIS | 4 0.04 92.70 TOXIC SKIN ERUPTION | 2 0.02 92.72 TRACHEAL HAEMORRHAGE | 1 0.01 92.73 TRACHEITIS | 1 0.01 92.74 TRANSAMINASES INCREASED | 4 0.04 92.78 TRANSIENT ISCHAEMIC ATTACK | 12 0.12 92.90 TRANSMISSION OF AN INFECTIOUS AGENT V.. | 1 0.01 92.91 TRANSPLANT | 1 0.01 92.92 TRANSPLANT FAILURE | 4 0.04 92.96 TRANSPLANT REJECTION | 2 0.02 92.98 TRANSPOSITION OF THE GREAT VESSELS | 1 0.01 92.99 TRANSURETHRAL PROSTATECTOMY | 2 0.02 93.01 TRAUMATIC BRAIN INJURY | 2 0.02 93.03 TREATMENT FAILURE | 2 0.02 93.05 TREATMENT NONCOMPLIANCE | 10 0.10 93.15 TREMOR | 42 0.42 93.57 TRICUSPID VALVE INCOMPETENCE | 6 0.06 93.63 TRIGEMINAL NERVE DISORDER | 1 0.01 93.64 TRIGEMINAL NEURALGIA | 2 0.02 93.66 TRIGGER FINGER | 2 0.02 93.68 TRISMUS | 5 0.05 93.73 TRISOMY 13 | 1 0.01 93.74 TRISOMY 21 | 1 0.01 93.75 TROPONIN INCREASED | 1 0.01 93.76 TUBERCULOSIS | 4 0.04 93.80 TUBULOINTERSTITIAL NEPHRITIS | 2 0.02 93.82 TUMOUR FLARE | 1 0.01 93.83 TUMOUR LOCAL INVASION | 1 0.01 93.84 TUMOUR PAIN | 1 0.01 93.85 TYMPANIC MEMBRANE PERFORATION | 1 0.01 93.86 TYPE 1 DIABETES MELLITUS | 1 0.01 93.87 TYPE 2 DIABETES MELLITUS | 9 0.09 93.96 TYRAMINE REACTION | 1 0.01 93.97 UBIQUINONE DECREASED | 1 0.01 93.98 ULCER | 2 0.02 94.00 ULCER HAEMORRHAGE | 2 0.02 94.02 ULCERATIVE KERATITIS | 1 0.01 94.03 ULNA FRACTURE | 1 0.01 94.04 ULTRASOUND ANTENATAL SCREEN ABNORMAL | 1 0.01 94.05 ULTRASOUND LIVER ABNORMAL | 1 0.01 94.06 UMBILICAL CORD ABNORMALITY | 1 0.01 94.07 UMBILICAL HERNIA | 1 0.01 94.08 UNDERWEIGHT | 1 0.01 94.09 UNEQUAL LIMB LENGTH | 1 0.01 94.10 UNEVALUABLE EVENT | 13 0.13 94.23 UNRESPONSIVE TO STIMULI | 6 0.06 94.29 UPPER EXTREMITY MASS | 1 0.01 94.30 UPPER GASTROINTESTINAL HAEMORRHAGE | 4 0.04 94.34 UPPER LIMB FRACTURE | 2 0.02 94.36 UPPER RESPIRATORY TRACT INFECTION | 5 0.05 94.41 UPPER RESPIRATORY TRACT INFLAMMATION | 1 0.01 94.42 URETERIC OBSTRUCTION | 2 0.02 94.44 URETERIC STENOSIS | 1 0.01 94.45 URETHRAL HAEMORRHAGE | 1 0.01 94.46 URETHRAL PAIN | 2 0.02 94.48 URINARY INCONTINENCE | 6 0.06 94.54 URINARY RETENTION | 10 0.10 94.64 URINARY TRACT DISORDER | 1 0.01 94.65 URINARY TRACT INFECTION | 29 0.29 94.94 URINARY TRACT INFECTION FUNGAL | 1 0.01 94.95 URINARY TRACT MALFORMATION | 1 0.01 94.96 URINE ABNORMALITY | 1 0.01 94.97 URINE ANALYSIS ABNORMAL | 2 0.02 94.99 URINE CALCIUM/CREATININE RATIO INCREA.. | 1 0.01 95.00 URINE ELECTROLYTES INCREASED | 1 0.01 95.01 URINE ODOUR ABNORMAL | 1 0.01 95.02 URINE OUTPUT DECREASED | 5 0.05 95.07 URINE OUTPUT INCREASED | 1 0.01 95.08 UROGENITAL DISORDER | 1 0.01 95.09 UROSEPSIS | 2 0.02 95.11 URTICARIA | 53 0.53 95.64 UTERINE DILATION AND CURETTAGE | 1 0.01 95.65 UTERINE HAEMORRHAGE | 1 0.01 95.66 UTERINE LEIOMYOMA | 3 0.03 95.69 UTERINE RUPTURE | 13 0.13 95.82 UVEITIS | 3 0.03 95.85 VAGINAL DISCHARGE | 3 0.03 95.88 VAGINAL HAEMORRHAGE | 10 0.10 95.98 VAGINAL INFECTION | 4 0.04 96.02 VAGINAL INFLAMMATION | 1 0.01 96.03 VAGINAL LESION | 1 0.01 96.04 VAGINAL SWELLING | 1 0.01 96.05 VAGINITIS BACTERIAL | 1 0.01 96.06 VARICES OESOPHAGEAL | 1 0.01 96.07 VARICOPHLEBITIS | 1 0.01 96.08 VARICOSE VEIN | 1 0.01 96.09 VASCULAR GRAFT | 1 0.01 96.10 VASCULITIS | 4 0.04 96.14 VASOSPASM | 1 0.01 96.15 VEIN DISORDER | 1 0.01 96.16 VENOOCCLUSIVE LIVER DISEASE | 2 0.02 96.18 VENOUS INSUFFICIENCY | 3 0.03 96.21 VENOUS STENOSIS | 1 0.01 96.22 VENOUS THROMBOSIS | 2 0.02 96.24 VENTRICULAR ARRHYTHMIA | 1 0.01 96.25 VENTRICULAR DYSFUNCTION | 1 0.01 96.26 VENTRICULAR EXTRASYSTOLES | 3 0.03 96.29 VENTRICULAR FIBRILLATION | 4 0.04 96.33 VENTRICULAR HYPOKINESIA | 3 0.03 96.36 VENTRICULAR SEPTAL DEFECT | 8 0.08 96.44 VENTRICULAR TACHYCARDIA | 5 0.05 96.49 VERTIGO | 13 0.13 96.62 VESTIBULITIS | 2 0.02 96.64 VICTIM OF ABUSE | 1 0.01 96.65 VICTIM OF CHILD ABUSE | 1 0.01 96.66 VICTIM OF CRIME | 1 0.01 96.67 VICTIM OF HOMICIDE | 1 0.01 96.68 VIOLENCE-RELATED SYMPTOM | 1 0.01 96.69 VIRAL HAEMORRHAGIC CYSTITIS | 1 0.01 96.70 VIRAL INFECTION | 6 0.06 96.76 VIRAL LOAD INCREASED | 1 0.01 96.77 VIRAL MYOCARDITIS | 1 0.01 96.78 VIRAL PERICARDITIS | 1 0.01 96.79 VISCERAL OEDEMA | 1 0.01 96.80 VISION BLURRED | 34 0.34 97.14 VISUAL ACUITY REDUCED | 9 0.09 97.23 VISUAL BRIGHTNESS | 1 0.01 97.24 VISUAL FIELD DEFECT | 2 0.02 97.26 VISUAL IMPAIRMENT | 19 0.19 97.45 VISUAL MIDLINE SHIFT SYNDROME | 1 0.01 97.46 VITAMIN B12 ABNORMAL | 2 0.02 97.48 VITAMIN B12 DEFICIENCY | 2 0.02 97.50 VITAMIN D DECREASED | 1 0.01 97.51 VITAMIN D DEFICIENCY | 2 0.02 97.53 VITREOUS HAEMORRHAGE | 2 0.02 97.55 VOCAL CORD PARALYSIS | 1 0.01 97.56 VOMITING | 75 0.75 98.31 VOMITING IN PREGNANCY | 2 0.02 98.33 VOMITING PROJECTILE | 1 0.01 98.34 VULVAL ABSCESS | 1 0.01 98.35 VULVOVAGINAL BURNING SENSATION | 1 0.01 98.36 VULVOVAGINAL DISCOMFORT | 2 0.02 98.38 VULVOVAGINITIS | 1 0.01 98.39 WALKING AID USER | 1 0.01 98.40 WATER INTOXICATION | 1 0.01 98.41 WEIGHT DECREASED | 57 0.57 98.98 WEIGHT FLUCTUATION | 1 0.01 98.99 WEIGHT GAIN POOR | 2 0.02 99.01 WEIGHT INCREASED | 29 0.29 99.30 WEIGHT LOSS POOR | 1 0.01 99.31 WHEELCHAIR USER | 1 0.01 99.32 WHEEZING | 6 0.06 99.38 WHITE BLOOD CELL COUNT ABNORMAL | 1 0.01 99.39 WHITE BLOOD CELL COUNT DECREASED | 8 0.08 99.47 WHITE BLOOD CELL COUNT INCREASED | 9 0.09 99.56 WHITE BLOOD CELL DISORDER | 1 0.01 99.57 WHITE CLOT SYNDROME | 1 0.01 99.58 WITHDRAWAL SYNDROME | 14 0.14 99.72 WOUND | 2 0.02 99.74 WOUND COMPLICATION | 1 0.01 99.75 WOUND DEHISCENCE | 1 0.01 99.76 WOUND DRAINAGE | 1 0.01 99.77 WOUND INFECTION | 1 0.01 99.78 WOUND INFECTION STAPHYLOCOCCAL | 1 0.01 99.79 WRIST FRACTURE | 6 0.06 99.85 WRONG DRUG ADMINISTERED | 11 0.11 99.96 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 3 0.03 99.99 ZYGOMYCOSIS | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015